{"config":{"lang":["en"],"separator":"[\\s\\-]+","pipeline":["stopWordFilter"],"fields":{"title":{"boost":1000.0},"text":{"boost":1.0},"tags":{"boost":1000000.0}}},"docs":[{"location":"","title":"Cardiac Imaging Resources","text":"<p>Fellowship reference for cardiac CT &amp; MRI \u2014 calculators, grading tables, and protocol guidance</p> \u26a1 Open Calculators \ud83e\uddf2 Cardiac MRI Cardiac CT <p>Reporting tips, key measurements, and links to scan protocols</p> Cardiac MRI <p>Sequences, protocol guides, troubleshooting, and reporting</p> Valves <p>Grading tables for stenosis/regurgitation; TAVR/TMVR/LAAO planning</p> Congenital HD <p>Key CHD entities with imaging pearls and MRI tips</p> Calculators <p>ECV, 4D flow shunt/regurgitation, and Simplified Bernoulli</p>"},{"location":"calculators/","title":"Calculators","text":"<p>Interactive tools for cardiac CT and MRI interpretation \u2014 runs locally in your browser, no data sent anywhere.</p> \ud83e\udec0 ECV Calculator <p>Extracellular volume fraction from T1 mapping (pre/post gadolinium + hematocrit). Provides partition coefficient and interpretation.</p> \ud83c\udf0a 4D Flow Analysis <p>Qp:Qs shunt fraction, regurgitant fractions, pulmonary flow split, and BSA-indexed cardiac outputs. Standard, Fontan, and quick modes.</p> \ud83d\udca8 Simplified Bernoulli <p>Peak pressure gradient from peak velocity. Severity grading by valve. TR jet \u2192 RVSP estimation.</p>"},{"location":"calculators/bernoulli/","title":"Simplified Bernoulli","text":"<p>Convert between peak velocity and pressure gradient using the simplified Bernoulli equation.</p> <p>Formula: \\(\\Delta P = 4 V_{max}^2\\)</p> Velocity \u2194 Pressure Gradient Peak Velocity (m/s) \u2194 Pressure Gradient (mmHg)"},{"location":"calculators/bernoulli/#stenosis-grading","title":"Stenosis Grading","text":"Aortic Mitral Pulmonary Tricuspid Severity Valve Area (cm\u00b2) V<sub>max</sub> (m/s) Peak Gradient (mmHg) Mean Gradient (mmHg) Normal \u22652.0 &lt;2.0 &lt;10 &lt;5 Mild 1.6\u20132.0 2.0\u20132.9 16\u201336 &lt;25 Moderate 1.0\u20131.5 3.0\u20133.9 36\u201364 25\u201340 Severe &lt;1.0 or indexed &lt;0.6 \u22654.0 \u226564 \u226540 Severity MVA (cm\u00b2) Mean Gradient (mmHg) PAP (mmHg) Normal &gt;2.0 -- -- Mild 1.5\u20132.0 &lt;5 &lt;30 Moderate 1.0\u20131.5 5\u201310 30\u201350 Severe &lt;1.0 &gt;10 &gt;50 Severity Peak Gradient (mmHg) Normal &lt;10 Mild 10\u201336 Moderate 36\u201364 Severe &gt;64 Category Mean Gradient (mmHg) Valve Area (cm\u00b2) Hemodynamically Significant &gt;5 &lt;1.0"},{"location":"calculators/ecv/","title":"ECV Calculator","text":"<p>Extracellular volume fraction from T1 mapping \u2014 requires pre- and post-contrast MOLLI (or ShMOLLI) and hematocrit.</p> ECV from T1 Mapping <p>Extracellular volume fraction from pre- and post-contrast MOLLI \u2014 requires hematocrit</p> Hematocrit (%) Pre-Gd T1 \u2014 Myo (ms) Pre-Gd T1 \u2014 Blood (ms) Post-Gd T1 \u2014 Myo (ms) Post-Gd T1 \u2014 Blood (ms) <p>Enter all T1 values and hematocrit to calculate ECV.</p>"},{"location":"calculators/ecv/#reference","title":"Reference","text":"<p>Formula: \\(ECV = (1 - Hct) \\times \\frac{\\Delta R1_{myo}}{\\Delta R1_{blood}}\\) where \\(\\Delta R1 = \\frac{1}{T1_{post}} - \\frac{1}{T1_{pre}}\\)</p> ECV (%) Interpretation Clinical Context &lt;30 Normal Normal extracellular matrix 30\u201332 Borderline Correlate with clinical context 32\u201340 Elevated Diffuse fibrosis / edema &gt;40 Markedly Elevated Consider amyloid or severe fibrosis <p>Measurement Tips</p> <ul> <li>Use the same 3 slices (base/mid/apex) for pre- and post-contrast MOLLI \u2014 identical slice positions matter</li> <li>Blood pool T1 measured from a ROI in the LV cavity (avoid trabeculae)</li> <li>Gadolinium should fully equilibrate before post-Gd MOLLI \u2014 ideally \u226510 min post-injection</li> <li>Hematocrit from same-day labs; point-of-care Hct is acceptable</li> <li>At 1.5T: native T1 ~950\u20131050 ms (myo), ~1600\u20131750 ms (blood); at 3T: ~1150\u20131300 ms (myo), ~1800\u20132000 ms (blood)</li> </ul>"},{"location":"calculators/flow/","title":"4D Flow Analysis","text":"<p>Enter measurements from 4D Flow MRI or 2D Phase Contrast. All inputs in L/min. Supports ranges (e.g. <code>4.5-4.9</code>).</p> Phase Contrast Flow Analysis <p>Net flow is primary input. Optional regurgitant volumes calculate RF%.</p> Patient Parameters (optional) Height (cm) Weight (kg) Heart Rate (bpm) BSA (m\u00b2) \u2014 Standard Circulation Fontan Circulation Vessel Flows (L/min) Aorta (net) Main PA (net) LPA RPA Regurgitation (optional) Stroke Volumes (optional) LVSV (mL) RVSV (mL) Units mL/beat L/min Aortic Mitral Pulmonic Tricuspid <p>Enter vessel flows to compute results.</p> Systemic &amp; Caval Flows (L/min) Aorta (net) Glenn/SVC Fontan conduit/IVC Pulmonary Flows (L/min) Main PA (net) LPA RPA LPV RPV Regurgitation (optional) Stroke Volumes (optional) LVSV (mL) RVSV (mL) Units mL/beat L/min Aortic Mitral Pulmonary Tricuspid <p>Enter Fontan circuit flows to compute results.</p>"},{"location":"cardiac_ct/","title":"Cardiac CT","text":"<p>Scanning protocols for cardiac CT are maintained in the Radiology Protocol Manager. This page covers reporting pearls and key measurements used during interpretation.</p>"},{"location":"cardiac_ct/#coronary-ct-angiography-ccta","title":"Coronary CT Angiography (CCTA)","text":""},{"location":"cardiac_ct/#cad-rads-20-reporting","title":"CAD-RADS 2.0 Reporting","text":"CAD-RADS Stenosis Recommendation 0 No stenosis No CAD 1 1\u201324% Minimal, non-obstructive 2 25\u201349% Mild, non-obstructive 3 50\u201369% Moderate \u2014 functional testing recommended 4A 70\u201399% (1\u20132 vessels) Severe \u2014 ICA or FFR-CT 4B 70\u201399% (LM or 3-vessel) Severe \u2014 heart team 5 Total occlusion N Non-diagnostic segment <p>Modifiers: <code>+HRP</code> (high-risk plaque), <code>+S</code> (stent), <code>+G</code> (graft), <code>+E</code> (exception), <code>+I</code> (ischemia)</p> <p>High-Risk Plaque Features</p> <p>Low attenuation plaque (&lt;30 HU), positive remodeling (RI &gt;1.1), napkin-ring sign, spotty calcification</p>"},{"location":"cardiac_ct/#tavr-planning-ct","title":"TAVR Planning CT","text":""},{"location":"cardiac_ct/#key-measurements","title":"Key Measurements","text":"Measurement Method Notes Aortic annulus Multi-planar (axial oblique, perpendicular to outflow) Mean diameter, perimeter, area \u2192 derived D Annular area Planimetry on perpendicular plane Guides device sizing LVOT diameter 3\u20135 mm below annulus Important for CoreValve-type devices Sinus of Valsalva Widest systolic dimension Distance from annulus to coronary ostia Coronary heights LCA &amp; RCA ostial height from annulus &lt;10\u201312 mm = higher occlusion risk Sinotubular junction Width at STJ Aortic root angle Aortic root to vertebral column Affects fluoroscopic projection Iliofemoral access Minimum luminal diameter, tortuosity, calcification MLD \u22655\u20136 mm for transfemoral <p>Bicuspid Aortic Valve</p> <p>Increased risk of paravalvular leak and annular rupture. Note raphe, cusp morphology (Sievers 0/1/2), and eccentric calcification.</p>"},{"location":"cardiac_ct/#tmvr-ttvr-planning-ct","title":"TMVR / TTVR Planning CT","text":"<ul> <li>Mitral annulus: D-shaped, measure perimeter and area in systole (perpendicular to LVOT)</li> <li>Neo-LVOT: Model potential LVOT obstruction \u2014 critical if &lt;170\u2013190 mm\u00b2</li> <li>Interatrial septum: Thickness and trajectory for transseptal approach</li> <li>Tricuspid annulus: Saddle-shaped; measure in systole; note associated RV dilation</li> </ul>"},{"location":"cardiac_ct/#laao-planning-ct","title":"LAAO Planning CT","text":"<p>Key Measurements</p> <ul> <li>LAA ostium: Max and min diameter + area (elliptical shape) \u2014 guides device size (+3\u20135 mm)</li> <li>LAA landing zone: 1\u20132 cm from ostium; measure max/min diameter</li> <li>LAA morphology: Chicken wing, cactus, windsock, cauliflower (\u2191 stroke risk)</li> <li>Thrombus: Residual enhancement on delayed phase (60 s) excludes thrombus</li> </ul>"},{"location":"cardiac_ct/#pericardial-disease","title":"Pericardial Disease","text":"Feature CT Finding Pericardial thickening &gt;3\u20134 mm (normally \u22642 mm) Calcification Suggest constrictive pericarditis Effusion Simple (&lt;30 HU) vs. complex/hemorrhagic Constrictive physiology Septal bounce on retrospective cine"},{"location":"cardiac_ct/#reporting-checklist","title":"Reporting Checklist","text":"CCTATAVR Planning <ul> <li>[ ] Coronary dominance</li> <li>[ ] Proximal, mid, distal segments for each vessel</li> <li>[ ] CAD-RADS classification + modifiers</li> <li>[ ] Non-cardiac findings (lungs, mediastinum, liver)</li> </ul> <ul> <li>[ ] Aortic valve morphology (tricuspid/bicuspid, calcification burden)</li> <li>[ ] Annular dimensions (perimeter-derived D, area, max/min)</li> <li>[ ] Sinus of Valsalva, STJ, aortic root angle</li> <li>[ ] Coronary ostial heights</li> <li>[ ] Ascending aorta diameter (annulus \u2192 arch)</li> <li>[ ] Access: iliac/femoral min luminal diameter, calcification, tortuosity</li> </ul>"},{"location":"cardiac_mri/","title":"Cardiac MRI \u2014 Overview &amp; Sequences","text":"<p>Overview of commonly used cardiac MRI sequences, their key purposes, and acquisition parameters.</p>"},{"location":"cardiac_mri/#common-cardiac-mri-sequences","title":"Common Cardiac MRI Sequences","text":"Sequence Type Primary Purpose Key Parameters Cine SSFP bSSFP (bright blood) Ventricular function, morphology, valve motion 25\u201335 phases, 6\u20138 mm slice, breath-hold, retrospective ECG gating LGE IR-GRE Myocardial scar, fibrosis, infiltration TI scout first (null normal myocardium); ~10\u201315 min post-Gd T1 MOLLI LL (Look-Locker) T1 mapping \u2192 ECV calculation Native + post-contrast; 5(3)3 or 5(3b)3 scheme T1 ShMOLLI Modified LL T1 mapping (shorter BH) Less accurate at long T1 T1 SASHA Saturation-recovery T1 mapping \u2014 heart rate independent Longer BH; reference at 3T T2 Mapping T2-prepared bSSFP Edema (myocarditis, acute MI) Normal ~45\u201355 ms at 1.5T T2 STIR / T2 BB BB-TSE Edema, masses, pericarditis T2* Multi-echo GRE Iron overload quantification Normal T2* &gt;20 ms; severe &lt;10 ms 4D Flow PC-VIPR or Cartesian Flow in all vessels; WSS; shunt quantification Long acquisition (10\u201320 min), retrospective 2D Phase Contrast Velocity-encoded GRE Flow quantification at specific vessels Set VENC 10\u201320% above expected peak velocity Perfusion (first-pass) T1w SSFP or GRE Ischemia detection; rest+stress 0.075\u20130.1 mmol/kg Gd; 3 SAX slices + long axis Black Blood (HASTE) SE EPI Morphology, vessel anatomy, masses Single-shot; good for rapid survey Dark Blood TSE IR-TSE Vessel wall, pericardium, masses Better SNR than HASTE; longer Tagging (DENSE/SENC) Grid or spectral Myocardial strain Circumferential strain normal ~ \u221220 to \u221225%"},{"location":"cardiac_mri/#normal-reference-values","title":"Normal Reference Values","text":""},{"location":"cardiac_mri/#lv-biplane-simpson-or-3d","title":"LV (Biplane Simpson or 3D)","text":"Parameter Male Female EDVi (mL/m\u00b2) 62\u201396 54\u201382 ESVi (mL/m\u00b2) 21\u201340 17\u201336 EF (%) 57\u201375 57\u201375 Mass index (g/m\u00b2) 50\u201388 38\u201370"},{"location":"cardiac_mri/#rv-axial-stack-or-sax","title":"RV (Axial stack or SAX)","text":"Parameter Male Female EDVi (mL/m\u00b2) 74\u2013108 58\u201398 ESVi (mL/m\u00b2) 25\u201350 18\u201345 EF (%) 52\u201369 55\u201372"},{"location":"cardiac_mri/#t1-t2-normal-ranges-field-strength-dependent","title":"T1 / T2 Normal Ranges (field-strength dependent)","text":"Sequence 1.5T (ms) 3T (ms) Native T1 (MOLLI) 950\u20131050 1150\u20131280 Post-Gd T1 350\u2013550 350\u2013550 T2 mapping 45\u201355 45\u201355 T2* (iron) &gt;20 (normal) &gt;20 (normal)"},{"location":"cardiac_mri/#troubleshooting","title":"Troubleshooting","text":"<p>Cardiac Anesthesia</p> <ul> <li>4 cardiac issues that will make anesthetists stressed if you ask them to do a study under GA:</li> <li>Severe aortic stenosis</li> <li>Pulmonary Hypertension</li> <li>Severe LV heart failure</li> <li>Arrhythmia (ventricular)</li> </ul> <p>Motion Artifacts (ghosting)</p> <ul> <li>Arrhythmia: switch to real-time cine (lower resolution but no ECG issues)</li> <li>Breathing: use free-breathing with navigator; check patient coaching</li> <li>Cine ghosting: check VENC if using velocity-encoded sequence; check shimming</li> </ul> <p>LGE \u2014 Wrong TI</p> <p>Always run a TI scout after gadolinium dosing. Re-run if myocardium not nulled (appears bright on PSIR inversion images).</p> <p>Banding Artifacts (bSSFP)</p> <p>Banding from B\u2080 inhomogeneity: re-shim, or switch to 1.5T equivalent (spoiled GRE / FIESTA at off-resonance range). More problematic at 3T.</p> <p>4D Flow Quality Check</p> <ul> <li>Velocity aliasing: increase VENC (but SNR decreases)</li> <li>Flow inconsistencies: SVC + IVC should \u2248 PA; Ao \u2248 PA in normal hearts</li> <li>Check background phase correction in post-processing software</li> </ul>"},{"location":"cardiac_mri/#standard-views","title":"Standard Views","text":"View Prescription Content 4-chamber (4CH) From axial showing RA/LA/RV/LV All four chambers; mitral and tricuspid valves 2-chamber (2CH) Perpendicular to 4CH through LV LA, LV, mitral valve 3-chamber (3CH) LVOT view LV, LVOT, aortic valve; rules out LVOTO Short axis (SAX) Perpendicular to LV long axis Stack base to apex for volumetry RVOT Free-hand, right-heart focus PA, pulmonic valve, RVOT Coronal / Oblique sag Free-hand Aorta, PA, aortic arch, great vessels"},{"location":"cardiac_mri/protocols/","title":"Cardiac MRI Protocols","text":"<p>Overview of standard cardiac MRI protocols and the sequences used in each.</p> Protocol Primary Indication Key Sequences Cardiac Function Ventricular volumes, EF, wall motion Cine SSFP (SAX + LAX), dark blood morphology Viability Cardiomyopathy, ischemic scar, fibrosis Function + LGE + T1 mapping (ECV) Stress Perfusion Suspected CAD, ischemia evaluation Rest + stress perfusion, LGE Congenital / 4D Flow CHD, shunt quantification, flow analysis Dark blood morphology, cine, 4D flow or 2D PC Cardiac Masses Cardiac tumor, thrombus, pericardial mass Multi-echo T1, T2, perfusion, LGE"},{"location":"cardiac_mri/protocols/#contrast-doses","title":"Contrast Doses","text":"Use Dose Agent Standard LGE / perfusion 0.1 mmol/kg (single) Gadolinium-based (macrocyclic preferred) Perfusion + LGE same study 0.1 mmol/kg for perfusion; additional 0.05\u20130.1 for LGE if needed \u2014 T1 mapping (ECV) 0.1 mmol/kg Record pre-contrast T1 first <p>NSF Risk</p> <p>Use macrocyclic agents (Group II) for patients with eGFR &lt;30 mL/min/1.73m\u00b2. Avoid linear agents. Discuss risk/benefit if eGFR &lt;15 or on dialysis.</p>"},{"location":"cardiac_mri/protocols/cardiac_function/","title":"Cardiac Function Protocol","text":"<p>Indications: Cardiomyopathy evaluation, pre/post-chemotherapy, valve disease follow-up, congenital disease, RV assessment, pre-operative evaluation.</p>"},{"location":"cardiac_mri/protocols/cardiac_function/#sequence-order","title":"Sequence Order","text":"# Sequence View Notes 1 Localizers 3-plane Quick survey 2 Dark blood HASTE Axial stack (thorax) Morphology survey; pericardium; pleura 3 Cine SSFP 4CH LV/RV function, mitral + tricuspid 4 Cine SSFP 2CH LV function, mitral 5 Cine SSFP 3CH (LVOT) LVOTO assessment, aortic valve 6 Cine SSFP SAX stack (base \u2192 apex in 8 mm steps) Volumetry \u2014 primary EF / EDV / ESV measurement 7 Cine SSFP RVOT Pulmonic valve, RVOT morphology 8 Cine SSFP Aortic valve (en face) Valve morphology, orifice 9 T2 mapping 3 SAX (base/mid/apex) Optional \u2014 if edema suspected"},{"location":"cardiac_mri/protocols/cardiac_function/#key-measurements-to-report","title":"Key Measurements to Report","text":"<ul> <li>LV: EDV, ESV, SV, EF, mass (indexed to BSA)</li> <li>RV: EDV, ESV, SV, EF (right-heart dedicated SAX or axial stack)</li> <li>Wall motion: Segmental (17-segment AHA model) \u2014 describe hypokinesis, akinesis, dyskinesis</li> <li>Pericardium: Effusion volume, thickening, calcification</li> <li>Valves: Qualitative assessment of regurgitation on cine</li> </ul> <p>SAX Volumetry Tips</p> <ul> <li>Include basal slices that show &gt;50% myocardium in the plane</li> <li>Contour from first slice with clear septal muscle (not AV plane) to apex</li> <li>RVOT can be tricky \u2014 sometimes exclude if partially through tricuspid plane</li> </ul>"},{"location":"cardiac_mri/protocols/cardiac_function/#reporting-template-structure","title":"Reporting Template Structure","text":"<pre><code>TECHNIQUE: CMR performed on [X]T scanner with cardiac gating. \nNo gadolinium contrast administered.\n\nLV: EDVi XX mL/m\u00b2, ESVi XX mL/m\u00b2, EF XX%, mass index XX g/m\u00b2.\nSegmental wall motion: [normal / regional hypokinesis \u2014 describe location]\n\nRV: EDVi XX mL/m\u00b2, EF XX%. Normal/Dilated/Reduced.\n\nValves: [qualitative from cine]\nPericardium: [normal / effusion / thickening]\nExtracardiac: [lungs, mediastinum]\n</code></pre>"},{"location":"cardiac_mri/protocols/cardiac_masses/","title":"Cardiac Masses Protocol","text":"<p>Indications: Suspected cardiac tumor, thrombus, pericardial mass, vegetation (supplementary to echo/CT).</p>"},{"location":"cardiac_mri/protocols/cardiac_masses/#sequence-order","title":"Sequence Order","text":"# Sequence View Notes 1 Localizers 3-plane 2 Dark blood HASTE Axial stack Mass location, morphology, extracardiac extent 3 Cine SSFP 4CH, 2CH, 3CH, SAX, targeted views Mass mobility, attachment, valve obstruction, chamber function 4 T2 mapping Targeted to mass Edema / cystic content 5 T2 STIR Targeted views High signal in hemangioma, cyst, malignant masses 6 T1 w/o fat sat Targeted views Detect T1 bright signal (fat, thrombus, hemorrhage) 7 T1 + fat sat Same views Fat suppression confirms lipomatous lesion 8 Multi-echo T2* Targeted Iron content (rare); cystic vs. solid \u2014 \u2014 Inject gadolinium (0.1 mmol/kg) 9 Dynamic perfusion Targeted Enhancement kinetics \u2014 perfused vs. avascular 10 Early post-Gd T1 Targeted Immediate enhancement 11 TI Scout \u2014 12 LGE SAX stack + targeted mass views Delayed enhancement pattern"},{"location":"cardiac_mri/protocols/cardiac_masses/#mass-characterization","title":"Mass Characterization","text":""},{"location":"cardiac_mri/protocols/cardiac_masses/#tissue-characteristics-by-cmr","title":"Tissue Characteristics by CMR","text":"Feature Low T1 High T1 Low T2 High T2 Enhances Thrombus \u2713 (acute) \u2713 (subacute/chronic) \u2713 \u2717 No (avascular) Myxoma \u2713 \u2717 \u2717 \u2713 Yes (heterogeneous) Lipoma \u2717 \u2713 (fat) \u2717 \u2713 No Fibroelastoma \u2713 \u2717 \u2717 \u2717 Variable Hemangioma \u2713 \u2717 \u2717 \u2713 \u2713 Yes (early, intense) Angiosarcoma Variable \u2717 \u2717 \u2713 Yes (heterogeneous, nodular) Metastasis Variable Variable Variable Variable Yes Pericardial cyst \u2713 \u2717 \u2717 \u2713 \u2713 No <p>Thrombus Key Feature</p> <p>Thrombus does not enhance on perfusion or delayed LGE. A perfused mass enhances \u2014 not a thrombus.</p>"},{"location":"cardiac_mri/protocols/cardiac_masses/#common-cardiac-masses","title":"Common Cardiac Masses","text":""},{"location":"cardiac_mri/protocols/cardiac_masses/#benign","title":"Benign","text":"Mass Location Characteristics Myxoma LA (fossa ovalis) 75%, RA 15% Heterogeneous, mobile, jelly-like; T2 bright, variable enhancement Lipoma Anywhere (RA most common) Homogeneous T1 bright, suppressed on fat sat Papillary fibroelastoma Valve leaflets Tiny, mobile; best seen on echo; low T1/T2, poor CMR visualization Hemangioma RV free wall Very T2 bright; early intense enhancement Rhabdomyoma Ventricular myocardium Infants; multiple; tuberous sclerosis Fibroma IVS / LV free wall T1 iso, T2 dark, intense LGE (dense fibrous tissue) Pericardial cyst Right costophrenic angle Simple cyst; T2 bright, no enhancement"},{"location":"cardiac_mri/protocols/cardiac_masses/#malignant","title":"Malignant","text":"Mass Location Characteristics Angiosarcoma RA, pericardium Nodular, hemorrhagic, T2 bright; \"sunray\" appearance; aggressive enhancement Undifferentiated sarcoma LA (mimics myxoma) Invasion, heterogeneous enhancement Lymphoma Pericardium, myocardium Diffuse infiltration; preserves anatomy Metastasis Any chamber / pericardium History of primary malignancy; lung, breast, melanoma most common Mesothelioma Pericardium Diffuse pericardial involvement"},{"location":"cardiac_mri/protocols/cardiac_masses/#reporting-template","title":"Reporting Template","text":"<pre><code>TECHNIQUE: CMR with gadolinium for cardiac mass evaluation. \nMulti-echo T1/T2/STIR sequences, dynamic perfusion, and LGE performed.\n\nMASS:\nLocation: [chamber / valve / pericardium]; attachment site: [describe]\nSize: XX \u00d7 XX \u00d7 XX mm\nMobility: [mobile / sessile / broad-based]\n\nSIGNAL CHARACTERISTICS:\nT1: [iso/hypo/hyperintense] [fat saturation: unchanged/suppressed]\nT2 / STIR: [iso/hypo/hyperintense]\nPerfusion: [enhances / does not enhance \u2014 avascular]\nLGE: [delayed enhancement / none]\n\nIMPRESSION:\n[Most likely diagnosis] based on [location, characteristics, enhancement pattern].\n[Differential considerations if applicable]\n[Recommend echo correlation / TEE / surgical evaluation]\n</code></pre>"},{"location":"cardiac_mri/protocols/congenital_4dflow/","title":"Congenital / 4D Flow Protocol","text":"<p>Indications: Congenital heart disease (ASD, VSD, TOF, TGA, Fontan, coarctation), shunt quantification, valvular flow (AR/PR from CMR), vessel stenosis assessment.</p>"},{"location":"cardiac_mri/protocols/congenital_4dflow/#sequence-order","title":"Sequence Order","text":"# Sequence View Notes 1 Localizers 3-plane 2 Dark blood HASTE Axial stack (thorax) Situs, connections, great vessel relationships 3 Dark blood HASTE Coronal / oblique sagittal Aortic arch, PA, SVC/IVC anatomy 4 Cine SSFP 4CH, 2CH, 3CH LV/RV function; AV valve regurgitation 5 Cine SSFP SAX stack (LV) LV volumetry and wall motion 6 Cine SSFP SAX stack (RV-focused if needed) RV volumetry; free wall 7 Cine SSFP RVOT, LVOT, aortic arch, PA bifurcation Site-specific cines for stenosis and morphology 8 2D Phase Contrast Perpendicular to Ao, PA, LPA, RPA Flow quantification; Qp:Qs 9 4D Flow Volume covering heart and great vessels Replaces 2D PC if available; post-process for all vessels 10 LGE (if Gd given) SAX + LAX RV insertion points; fibrosis in systemic RV <p>2D PC vs. 4D Flow</p> <p>2D PC is faster and works well when you know the specific vessels to measure. 4D flow allows retrospective plane placement and WSS/visualization \u2014 better for complex anatomy or when vessels are uncertain.</p>"},{"location":"cardiac_mri/protocols/congenital_4dflow/#phase-contrast-2d-pc-practical-tips","title":"Phase Contrast (2D PC) \u2014 Practical Tips","text":"<ul> <li>VENC: Set 10\u201320% above expected peak velocity. Aliasing artifacts = increase VENC. Too high VENC = poor SNR.</li> <li>Typical: Ao ~150\u2013180 cm/s, PA ~100\u2013130 cm/s, SVC ~60\u201380 cm/s</li> <li>Plane placement: Perpendicular to vessel long axis; avoid turbulence zones (place 1\u20132 cm from valve)</li> <li>Background phase correction: Apply in post-processing if available (e.g., use stationary tissue outside vessel)</li> </ul>"},{"location":"cardiac_mri/protocols/congenital_4dflow/#qpqs-calculation","title":"Qp:Qs Calculation","text":"<p>Standard: \\(\\frac{Qp}{Qs} = \\frac{\\text{PA net flow}}{\\text{Ao net flow}}\\)</p> <p>If LPA + RPA measured: use sum as Qp.</p> <p>Use the 4D Flow Calculator on the Calculators page.</p>"},{"location":"cardiac_mri/protocols/congenital_4dflow/#regurgitant-fraction","title":"Regurgitant Fraction","text":"<p>\\(RF = \\frac{\\text{Backward flow}}{\\text{Forward flow}} \\times 100\\%\\)</p> RF Severity &lt;20% Trivial/Mild 20\u201339% Moderate \u226540% Severe"},{"location":"cardiac_mri/protocols/congenital_4dflow/#key-reporting-elements","title":"Key Reporting Elements","text":"<ul> <li>Situs and connections: Situs (solitus/inversus/ambiguous), visceroatrial concordance, AV and ventriculoarterial concordance</li> <li>Shunts: Qp:Qs, shunt direction, size of defect on cine</li> <li>Biventricular function: EDVi, EF for both ventricles (BSA-indexed)</li> <li>Flow measurements: Net flows (mL/beat) for Ao, PA, LPA, RPA; RF for pulmonary regurgitation</li> <li>Stenosis: Gradient by modified Bernoulli from peak PC velocity</li> <li>LPA:RPA ratio: Normal ~55:45; &gt;60:40 = asymmetric flow (branch PA stenosis)</li> <li>Collateral flow (Fontan): Qp \u2212 Fontan flow; &gt;20% suggests significant aortopulmonary collaterals</li> </ul>"},{"location":"cardiac_mri/protocols/congenital_4dflow/#reporting-template-chd","title":"Reporting Template (CHD)","text":"<pre><code>TECHNIQUE: CMR [with/without] gadolinium on [X]T scanner.\nMorphologic cine and flow assessment performed.\n\nSITUS AND CONNECTIONS:\nSitus [solitus/inversus]. [AV concordance/discordance]. [VA concordance/discordance].\n[Describe septal defects, shunts, outflow tract abnormalities]\n\nVENTRICULAR FUNCTION:\nLV: EDVi XX mL/m\u00b2, EF XX%. [Normal/Dilated/Hypertrophied]\nRV: EDVi XX mL/m\u00b2, EF XX%. [Normal/Dilated]\n\nFLOW ANALYSIS:\nAo net flow: XX mL/beat. PA net flow: XX mL/beat.\nQp:Qs: X.X ([interpretation])\nLPA: XX mL/beat (XX% of Qp). RPA: XX mL/beat (XX% of Qp).\n[Pulmonary RF: XX% \u2014 [mild/moderate/severe] PR]\n\nIMPRESSION:\n[Primary diagnosis with hemodynamic summary]\n</code></pre>"},{"location":"cardiac_mri/protocols/stress_perfusion/","title":"Stress Perfusion Protocol","text":"<p>Indications: Known or suspected CAD, ischemia evaluation (alternative to nuclear), pre/post revascularization assessment.</p> <p>Stress agents: Adenosine (140 mcg/kg/min \u00d7 4\u20136 min), Regadenoson (0.4 mg bolus), Dobutamine (10\u201340 mcg/kg/min \u2014 for bSSFP cine stress wall motion if vasodilator contraindicated)</p>"},{"location":"cardiac_mri/protocols/stress_perfusion/#contraindications-to-vasodilator-stress","title":"Contraindications to Vasodilator Stress","text":"<p>Contraindications</p> <ul> <li>Active bronchospasm / severe asthma</li> <li>High-degree AV block (2\u00b0 or 3\u00b0) without pacemaker</li> <li>Systolic BP &lt;90 mmHg</li> <li>Dipyridamole within 24 h (potentiates adenosine)</li> <li>Caffeine within 12 h (blocks adenosine receptors \u2014 hold coffee day of scan)</li> </ul>"},{"location":"cardiac_mri/protocols/stress_perfusion/#sequence-order","title":"Sequence Order","text":"# Sequence View Notes 1 Localizers 3-plane 2 Dark blood HASTE Axial Morphology 3 Cine SSFP 4CH, 2CH, 3CH, RVOT, SAX Baseline function / wall motion 4 Rest Perfusion 3 SAX (base/mid/apex) + 4CH 0.075\u20130.1 mmol/kg Gd bolus at ~2 mL/s 5 Rest cines (repeat if wall motion question) SAX Optional 6 \u2014 Begin stress agent infusion Allow 2\u20134 min before stress imaging 7 Stress Perfusion Same 3 SAX slices At peak stress; same contrast dose 8 Wait 10\u201315 min \u2014 Gadolinium equilibrates 9 TI Scout Mid-SA 10 LGE SAX stack + LAX Scar assessment <p>Contrast Dose</p> <p>Use half-dose (0.05\u20130.075 mmol/kg) per perfusion acquisition to avoid T2* saturation artifact. Some protocols use full dose (0.1) \u2014 be consistent with your institution.</p>"},{"location":"cardiac_mri/protocols/stress_perfusion/#perfusion-image-interpretation","title":"Perfusion Image Interpretation","text":""},{"location":"cardiac_mri/protocols/stress_perfusion/#normal-vs-abnormal","title":"Normal vs. Abnormal","text":"<ul> <li>Normal: Uniform signal uptake in myocardium following gadolinium bolus. LV myocardium brightens uniformly from endo to epi.</li> <li>Perfusion defect: Subendocardial or transmural dark region on first-pass images, corresponding to territory of stenosed vessel.</li> <li>Dark rim artifact: Thin (1 pixel) subendocardial dark rim \u2014 common, especially at base. Not a true defect if limited to 1 slice and no corresponding LGE.</li> </ul>"},{"location":"cardiac_mri/protocols/stress_perfusion/#coronary-territory","title":"Coronary Territory","text":"Territory Coronary Artery Anterior, anteroseptal LAD Lateral, posterolateral LCx Inferior, inferoseptal RCA (right dominant) Inferior lateral LCx (left dominant) Septal perforators LAD proximal"},{"location":"cardiac_mri/protocols/stress_perfusion/#ischemia-vs-scar","title":"Ischemia vs. Scar","text":"Finding Interpretation Stress defect + No LGE Ischemia (viable, stunned, or hibernating myocardium) \u2014 candidate for revascularization Stress defect + LGE (&gt;50% transmural) Fixed scar \u2014 revascularization unlikely to help Stress defect + LGE (&lt;50% transmural) Mixed \u2014 some viable myocardium No stress defect + No LGE Normal \u2014 no significant ischemia or scar"},{"location":"cardiac_mri/protocols/stress_perfusion/#reporting-template","title":"Reporting Template","text":"<pre><code>TECHNIQUE: CMR stress perfusion with [vasodilator]. \nGadolinium [dose/agent] administered for rest and stress perfusion.\n\nSTRESS PERFUSION:\n[Normal uniform perfusion / perfusion defect in X territory, subendocardial/transmural, at stress only/rest and stress]\n\nREST PERFUSION: [Normal / defect \u2014 fixed]\n\nLGE: [None / transmural scar in X segment(s), X% extent]\n\nWALL MOTION (stress): [Normal / new RWMA in X territory at stress]\n\nIMPRESSION:\n[Normal study / Evidence of ischemia in X territory / Fixed scar / Mixed ischemia and scar]\n</code></pre>"},{"location":"cardiac_mri/protocols/viability/","title":"Viability Protocol","text":"<p>Indications: Ischemic cardiomyopathy (scar quantification for revascularization decision), non-ischemic cardiomyopathy characterization (HCM, DCM, myocarditis, infiltrative), ECV calculation.</p>"},{"location":"cardiac_mri/protocols/viability/#sequence-order","title":"Sequence Order","text":"# Sequence View Notes 1 Localizers 3-plane 2 Dark blood HASTE Axial Morphology 3 Native T1 MOLLI 3 SAX (base/mid/apex) Must be done before contrast 4 Cine SSFP 4CH, 2CH, 3CH, SAX stack Function 5 T2 mapping 3 SAX Edema (myocarditis workup) 6 T2 STIR 4CH, SAX Edema \u2014 regional \u2014 \u2014 Inject gadolinium (0.1 mmol/kg) Note time and dose 7 Post-Gd T1 MOLLI Same 3 SAX slices as native \u226515 min post-injection \u2014 wait for equilibrium 8 TI Scout Mid-SA Determine TI to null normal myocardium 9 LGE SAX stack Adjusted TI from scout 10 LGE 4CH, 2CH, 3CH, RVOT Orthogonal views 11 Phase-sensitive IR (PSIR) SAX + LAX If available \u2014 better null tolerance"},{"location":"cardiac_mri/protocols/viability/#lge-patterns-and-diagnosis","title":"LGE Patterns and Diagnosis","text":"Pattern Distribution Likely Diagnosis Subendocardial / transmural Coronary territory Ischemic scar Mid-wall Septal (IVS) \"stripe\" DCM, myocarditis, LBBB Subepicardial Lateral wall Myocarditis (focal) Diffuse subendocardial Global, circumferential Amyloid; also consider ECV RV insertion points Bilateral septal junctions Pressure overload (pulm HTN, TOF) Patchy / geographic HCM segments HCM \u2014 correlates with arrhythmia risk Pericardium Delayed enhancement Pericarditis <p>Ischemic vs. Non-Ischemic</p> <p>Ischemic scar always starts at the endocardium and may extend transmurally. Non-ischemic patterns (mid-wall, subepicardial, RV insertion) are never endocardial-dominant.</p>"},{"location":"cardiac_mri/protocols/viability/#transmural-extent-and-viability","title":"Transmural Extent and Viability","text":"Transmural Extent Likelihood of Functional Recovery with Revascularization 0% (no LGE) High 1\u201325% High 26\u201350% Intermediate 51\u201375% Unlikely &gt;75% Very unlikely"},{"location":"cardiac_mri/protocols/viability/#ecv-calculation","title":"ECV Calculation","text":"<p>Formula: \\(ECV = (1 - Hct) \\times \\frac{\\Delta R1_{myo}}{\\Delta R1_{blood}}\\)</p> <p>Where \\(\\Delta R1 = \\frac{1}{T1_{post}} - \\frac{1}{T1_{pre}}\\) (in ms\u207b\u00b9)</p> <p>Use the ECV Calculator on the Calculators page.</p> ECV (%) Interpretation &lt;25 Normal 25\u201330 Borderline 30\u201340 Diffuse fibrosis / edema &gt;40 Markedly elevated \u2014 amyloid? <p>Amyloid Pattern</p> <p>High native T1, high ECV, diffuse subendocardial LGE, difficulty nulling myocardium, small LV with thick walls + preserved/reduced EF. RV involvement common.</p>"},{"location":"cardiac_mri/protocols/viability/#reporting-template","title":"Reporting Template","text":"<pre><code>TECHNIQUE: CMR with gadolinium contrast [dose/agent]. \nT1 mapping pre- and post-contrast performed. LGE images obtained XX min post-injection.\n\nLV: EDVi XX mL/m\u00b2, ESVi XX mL/m\u00b2, EF XX%, mass index XX g/m\u00b2.\n\nLGE FINDINGS:\n[Segment] \u2014 [extent]% transmural LGE in an [ischemic/non-ischemic] pattern.\nMax transmural extent: XX%.\nTotal LGE burden: XX% of LV myocardial mass.\n\nT1 MAPPING (MOLLI):\nNative T1: XX ms (ref 950\u20131050 ms at 1.5T)\nPost-Gd T1: XX ms\nECV: XX% (Hct XX%)\n\nIMPRESSION:\n[Ischemic cardiomyopathy with scar / Non-ischemic pattern consistent with DCM / myocarditis / amyloid, etc.]\n</code></pre>"},{"location":"congenital/","title":"Congenital Heart Disease","text":"<p>CMR reporting template and reference for imaging pearls in common CHD entities.</p> Normal TOF TGA ccTGA DORV ASD VSD Fontan CoA Ebstein AVSD Segmental Analysis Template \ud83d\udccb Copy Template              <p>Situs: Situs solitus by normal spleen in the left upper quadrant and normal pulmonary arteries and airways relationships.</p> <p>Cavae: Single right-sided SVC and single right-sided IVC drain to the right atrium unobstructed.</p> <p>Pulmonary Veins: Two right-sided pulmonary vein(s) and Two left-sided pulmonary vein(s) drain to the left atrium. No evidence of compression, stenosis or anomalous pulmonary venous return.</p> <p>Atria: No gross interatrial communication.</p> <p>Atrioventricular Connection: Concordant. An endocardial cushion and two distinct atrioventricular valves are present.</p> <p>Ventricles: D-loop with levocardia. Both ventricles are normal in size, morphology and function. No gross interventricular communication.</p> <p>Ventriculoarterial Connection: Concordant. Main pulmonary artery courses anterior and to the left of the ascending aorta, consistent with normal position of the great arteries.</p> <p>Coronary Arteries: Right and left coronary arteries originate from their expected sinuses of Valsalva.</p> <p>Aorta: Left-sided aortic arch with normal branching pattern. No evidence of aneurysm, coarctation or major aorto-pulmonary collateral arteries.</p> <p>Pulmonary Arteries: Central pulmonary arteries are patent. No evidence of dilatation or stenosis.</p> <p>Miscellaneous: None.</p> <p>Using the Template</p> <p>Click on any lesion tab below to automatically update the template with lesion-specific findings. The template will highlight key anatomic features for each CHD entity. Click the Copy Template button to copy the formatted text to your clipboard.</p>"},{"location":"congenital/#individual-lesion-pages","title":"Individual Lesion Pages","text":"<ul> <li>Tetralogy of Fallot (TOF)</li> <li>Transposition of the Great Arteries (TGA)</li> <li>Congenitally Corrected TGA (ccTGA)</li> <li>Double Outlet Right Ventricle (DORV)</li> <li>Atrial Septal Defect (ASD)</li> <li>Ventricular Septal Defect (VSD)</li> <li>Fontan Circulation</li> <li>Coarctation of the Aorta (CoA)</li> <li>Ebstein Anomaly</li> <li>Atrioventricular Septal Defect (AVSD)</li> </ul>"},{"location":"congenital/#general-mri-tips","title":"General MRI Tips","text":"<p>General Approach</p> <ol> <li>Morphology first \u2014 dark blood (HASTE/TSE) axial stack for situs, connections, great vessel relationships</li> <li>Cine function \u2014 SAX stack of each ventricle (measure volumes separately)</li> <li>Flow \u2014 2D PC or 4D flow at Ao, PA, LPA, RPA, any shunt vessel</li> <li>LGE \u2014 assess fibrosis, especially in systemic RV patients</li> <li>T1/T2 mapping \u2014 if myocarditis, infiltrative, or congestive hepatopathy suspected</li> </ol> <p>Breath-holding: Use free-breathing with respiratory navigator for uncooperative patients or complex anatomy requiring long sequences.</p> <p>Sedation/anesthesia: Required for young children; coordinate with anesthesia for timing of sequences.</p>"},{"location":"congenital/asd/","title":"Atrial Septal Defect (ASD)","text":""},{"location":"congenital/asd/#classification","title":"Classification","text":"Type Prevalence Key Features Secundum 70% Central defect in fossa ovalis; most common Primum 15% Lower, involves AV valve tissue; part of AVSD spectrum Sinus venosus 10% Defect near SVC or IVC; often with anomalous PV return Coronary sinus 5% Rare; drain to coronary sinus"},{"location":"congenital/asd/#hemodynamic-significance","title":"Hemodynamic Significance","text":"<p>Shunt magnitude from 4D Flow: - Qp:Qs &lt;1.5: Small defect, typically asymptomatic; closure not routinely indicated - Qp:Qs 1.5\u20132.0: Moderate; warrants monitoring - Qp:Qs &gt;2.0: Large; generally indicated for closure to prevent RV dilation and late complications</p> <p>Volume overload signs: - RV dilation - RA enlargement - LV compression (RV dilation in diastole)</p>"},{"location":"congenital/asd/#4d-flow-assessment","title":"4D Flow Assessment","text":"<ul> <li>Qp:Qs calculation: Pulmonary artery net flow vs aortic net flow</li> <li>Shunt location: 4D flow can visualize the actual defect and shunt vector</li> <li>Anomalous pulmonary venous return: Especially in sinus venosus ASD (right upper PV commonly drains to SVC)</li> </ul>"},{"location":"congenital/asd/#closure-consideration","title":"Closure Consideration","text":"<p>Sizing for transcatheter closure: - TEE provides stretched balloon diameter (hemodynamic) - CT/CMR provides static anatomic measurements of rims and defect diameter - Adequate rims needed for device stability (usually &gt;5 mm)</p> <p>Surgical closure: If anatomy unsuitable for device (rims too short, multiple defects, or PV anomaly requiring surgical correction)</p>"},{"location":"congenital/asd/#long-term-follow-up","title":"Long-term Follow-up","text":"<p>Post-closure assessment by echocardiography or cardiac CT to ensure device position and assess for residual shunting.</p>"},{"location":"congenital/avsd/","title":"Atrioventricular Septal Defect (AVSD)","text":""},{"location":"congenital/avsd/#anatomy","title":"Anatomy","text":"<p>Hallmark: Deficiency of the atrioventricular septum resulting in: - Primum atrial septal defect: Opening between atria - Inlet ventricular septal defect: Opening between ventricles - Common atrioventricular valve: Single valve tissue bridging both atria and ventricles</p> <p>Associated features: - Left AV valve cleft: Separation between left superior and inferior bridging leaflets - Goose-neck deformity: Elongation and narrowing of left ventricular outflow tract (LVOT) - Anterior aortic position: Relative to posteriorly positioned pulmonary artery</p>"},{"location":"congenital/avsd/#classification","title":"Classification","text":"Type Features Partial AVSD (Ostium primum ASD) Primum ASD only; individual AV valves present; cleft in MV common Intermediate AVSD Small inlet VSD; common AV valve tissue above &amp; below Complete AVSD Large primum ASD + inlet VSD; single common AV valve Rastelli types A (symmetric), B (asymmetric), C (asymmetric with displacement)"},{"location":"congenital/avsd/#hemodynamics","title":"Hemodynamics","text":"<p>Left-to-right shunting: - Atrial level (primum ASD) - Ventricular level (inlet VSD) - Magnitude depends on defect size and relative AV valve insufficiency</p> <p>Associated pulmonary hypertension: - Common in complete AVSD if unrepaired - Contributes to progressive left AV valve regurgitation</p>"},{"location":"congenital/avsd/#cmr-assessment","title":"CMR Assessment","text":""},{"location":"congenital/avsd/#morphology","title":"Morphology","text":"<ul> <li>Defect extent: Dark blood imaging (HASTE/TSE) axial and coronal views delineate primum ASD and inlet VSD</li> <li>Common AV valve assessment: Identify single vs cleft valve</li> <li>LVOT narrowing: Sagittal views to assess goose-neck deformity and degree of left AV valve override</li> </ul>"},{"location":"congenital/avsd/#ventricular-function","title":"Ventricular Function","text":"<ul> <li>LV volume and EF: Secondary LV dilation from ASD and VSD</li> <li>RV volume and EF: RV dilation from atrial-level shunting</li> <li>Septation: Position of bridging leaflets at AV junction level</li> </ul>"},{"location":"congenital/avsd/#av-valve-regurgitation","title":"AV Valve Regurgitation","text":"<ul> <li>Left AV valve: Most commonly insufficient; quantify by 4D flow</li> <li>Right AV valve: May have cleft; assess competence</li> <li>Severity scoring: Mild, moderate, severe regurgitation</li> </ul>"},{"location":"congenital/avsd/#flow-assessment","title":"Flow Assessment","text":"<ul> <li>4D flow: Quantify shunt magnitude (Qp:Qs)</li> <li>Bidirectional flow at defects: If pulmonary hypertension present</li> </ul>"},{"location":"congenital/avsd/#associated-findings","title":"Associated Findings","text":"<ul> <li>Down syndrome: Present in ~25% of patients with AVSD</li> <li>Heterotaxy: Disorders of situs may coexist (laterality issues)</li> <li>Other congenital lesions: TOF, hypoplastic left heart features may accompany</li> </ul>"},{"location":"congenital/avsd/#surgical-repair","title":"Surgical Repair","text":""},{"location":"congenital/avsd/#indications","title":"Indications","text":"<ul> <li>Significant shunting: Qp:Qs &gt;1.5 in partial AVSD, virtually all complete AVSD</li> <li>Symptomatic patients: Poor growth, recurrent infections</li> <li>Pulmonary hypertension prevention: Earlier repair if risk factors</li> </ul>"},{"location":"congenital/avsd/#technique","title":"Technique","text":"<ul> <li>Primary closure of primum ASD</li> <li>Closure of inlet VSD</li> <li>Reconstruction of cleft left AV valve</li> <li>Maintain separate AV valve orifices</li> </ul>"},{"location":"congenital/avsd/#post-repair-complications","title":"Post-repair Complications","text":"<ul> <li>Left AV valve regurgitation: May progress despite surgical repair</li> <li>Can necessitate valve replacement later in life</li> <li>Subaortic stenosis: Residual LVOT obstruction from goose-neck anatomy</li> <li>Arrhythmias: Heart block risk (proximity to conduction tissue)</li> <li>AV valve insufficiency recurrence: Valve leaflet degeneration</li> </ul>"},{"location":"congenital/avsd/#imaging-follow-up","title":"Imaging Follow-up","text":"<p>Serial CMR and/or echocardiography to monitor: - Ventricular volume and function - Residual shunting - Left AV valve regurgitation progression - LVOT obstruction (if present) - Arrhythmia development</p>"},{"location":"congenital/cctga/","title":"Congenitally Corrected Transposition of the Great Arteries (ccTGA)","text":""},{"location":"congenital/cctga/#overview","title":"Overview","text":"<p>Congenitally corrected transposition (also called L-transposition or L-TGA) is characterized by discordant atrioventricular and discordant ventriculoarterial connections. Despite the abnormal morphology, the physiology is \"corrected\" at rest because systemic venous return ultimately reaches the lungs, and pulmonary venous return reaches the systemic circulation\u2014however, the systemic right ventricle is at increased risk for ventricular dysfunction over time.</p>"},{"location":"congenital/cctga/#key-features","title":"Key Features","text":"<ul> <li>Concordance paradox: Two levels of discordance (\"double discordance\") result in concordant physiology</li> <li>L-loop ventricles: Left-sided morphologic left ventricle (subpulmonary), right-sided morphologic right ventricle (systemic)</li> <li>Levocardia (normally positioned heart) with inverted chambering</li> <li>Associated lesions very common: VSD, left AV valve regurgitation (systemic mitral valve), Ebstein-like tricuspid deformity, subaortic stenosis, conduction abnormalities</li> </ul>"},{"location":"congenital/cctga/#segmental-anatomy","title":"Segmental Anatomy","text":""},{"location":"congenital/cctga/#situs-and-orientation","title":"Situs and Orientation","text":"<ul> <li>Usually situs solitus but heterotaxy is common</li> <li>Levocardia with normal cardiac position despite inverted chamber arrangement</li> <li>May be associated with other situs abnormalities\u2014evaluate carefully</li> </ul>"},{"location":"congenital/cctga/#venous-drainage","title":"Venous Drainage","text":"<ul> <li>Systemic venous return (SVC + IVC) drains to morphologic left atrium (on right side)</li> <li>Pulmonary venous return drains to morphologic right atrium (on left side)</li> <li>Anomalous pulmonary venous return is frequently associated\u2014check all four pulmonary veins</li> </ul>"},{"location":"congenital/cctga/#atrioventricular-connections-discordant","title":"Atrioventricular Connections (Discordant)","text":"<ul> <li>Morphologic right atrium \u2192 mitral valve \u2192 morphologic left ventricle (subpulmonary, in left position)</li> <li>Morphologic left atrium \u2192 tricuspid valve \u2192 morphologic right ventricle (systemic, in right position)</li> <li>Systemic mitral valve regurgitation is common (acts as systemic AV valve)</li> <li>Tricuspid valve abnormalities: Ebstein-like malposition with apical displacement and dysplasia</li> </ul>"},{"location":"congenital/cctga/#ventricles","title":"Ventricles","text":"<ul> <li>Morphologic left ventricle (subpulmonary):</li> <li>Small, compact morphology</li> <li>In left position (appears as \"RV\" on echocardiography)</li> <li> <p>Gives rise to pulmonary artery</p> </li> <li> <p>Morphologic right ventricle (systemic):</p> </li> <li>Dilated, thin-walled, less compliant</li> <li>In right position (appears as \"LV\" on echocardiography)</li> <li>Supports systemic circulation</li> <li> <p>Progressive dilation and dysfunction common in adulthood</p> </li> <li> <p>Ventricular septal defect: Present in ~70\u201380% of ccTGA cases</p> </li> <li>Usually perimembranous or subarterial</li> <li>May partially restrict left-to-right blood flow</li> </ul>"},{"location":"congenital/cctga/#ventriculoarterial-connections-discordant","title":"Ventriculoarterial Connections (Discordant)","text":"<ul> <li>Morphologic left ventricle (subpulmonary) \u2192 aorta (posteriorly positioned, arises from left-sided ventricle)</li> <li>Morphologic right ventricle (systemic) \u2192 pulmonary artery (anteriorly positioned, arises from right-sided ventricle)</li> <li>Great arteries typically anterior\u2013posterior relationship or side-by-side</li> </ul>"},{"location":"congenital/cctga/#coronary-arteries","title":"Coronary Arteries","text":"<ul> <li>Mirror-image coronary pattern is typical</li> <li>Right coronary artery arises from left-facing sinus (anterior)</li> <li>Left coronary system arises from right-facing sinus (posterior)</li> <li>Coronary ostia may be higher or in abnormal positions</li> <li>Critical for surgical planning (during potential future procedures)</li> </ul>"},{"location":"congenital/cctga/#aorta","title":"Aorta","text":"<ul> <li>Arises from morphologic left ventricle (in subpulmonary position but giving rise to aorta)</li> <li>Typically posterior and to the left relative to pulmonary artery</li> <li>Monitor for:</li> <li>Aortic root dilation</li> <li>Aortic regurgitation (related to VSD anatomy or endocarditis risk)</li> </ul>"},{"location":"congenital/cctga/#pulmonary-arteries","title":"Pulmonary Arteries","text":"<ul> <li>Branch pulmonary arteries usually patent and normally sized</li> <li>May show reduced flow if severe subaortic stenosis (left ventricular outflow tract obstruction)</li> </ul>"},{"location":"congenital/cctga/#associated-lesions","title":"Associated Lesions","text":"Lesion Frequency Clinical Significance VSD 70\u201380% Permits left-to-right shunt; position determines surgical approach Pulmonary stenosis 25\u201330% Variable; worsens systemic RV afterload Subaortic stenosis 10\u201320% LVOT obstruction; may require surgical relief Left AV valve regurgitation 40\u201350% Increases systemic RV volume load; progressive Tricuspid abnormality 10\u201330% Ebstein-like malposition; worsens TR Conduction abnormalities 50\u201380% Heart block common; may need pacing; CNS heterotaxy may have situs inversus totalis with right-sided IVC/SVC Heterotaxy/asplenia/polysplenia 5\u201310% Assess situs carefully"},{"location":"congenital/cctga/#cmr-imaging-pearls","title":"CMR Imaging Pearls","text":""},{"location":"congenital/cctga/#morphologic-assessment","title":"Morphologic Assessment","text":"<ol> <li>Recognizing the inversion: </li> <li>Use systemic venous return to identify the morphologic left atrium (receives SVC + IVC)</li> <li>Morphologic ventricle identification: trabeculae, papillary muscles, valve attachments</li> <li> <p>L-loop: Morphologic LV on left, morphologic RV on right (opposite of normal)</p> </li> <li> <p>Chamber size and function:</p> </li> <li>Measure systemic RV volumes and ejection fraction (may be reduced)</li> <li>Estimate subpulmonary LV size (usually small)</li> <li> <p>Quantify left (systemic mitral) and right AV valve regurgitation</p> </li> <li> <p>VSD localization:</p> </li> <li>Careful cine imaging in multiple planes to define VSD type</li> <li>Position relative to great arteries (important for operative planning)</li> </ol>"},{"location":"congenital/cctga/#flow-imaging","title":"Flow Imaging","text":"<ul> <li>4D flow or 2D PC through great arteries to assess:</li> <li>Systemic-to-pulmonary shunt (if VSD present)</li> <li>Systemic AV valve (mitral) regurgitation fraction</li> <li>Subaortic obstruction gradient</li> <li>Branch pulmonary artery flow balance</li> </ul>"},{"location":"congenital/cctga/#lgefibrosis-assessment","title":"LGE/Fibrosis Assessment","text":"<ul> <li>Assess for myocardial replacement fibrosis in systemic RV (related to chronic volume/pressure overload)</li> <li>Fibrosis correlates with ventricular dysfunction and arrhythmia risk</li> </ul>"},{"location":"congenital/cctga/#associated-anomalies","title":"Associated Anomalies","text":"<ul> <li>Pulmonary and systemic venous return anatomy</li> <li>Coronary artery origins and course (may require dedicated coronary CMR protocol)</li> <li>Situs and other congenital associations</li> </ul>"},{"location":"congenital/cctga/#clinical-staging-and-natural-history","title":"Clinical Staging and Natural History","text":""},{"location":"congenital/cctga/#uncorrected-native-cctga","title":"Uncorrected (Native) ccTGA","text":"<ul> <li>Presentation: Often cyanotic if VSD absent or restrictive; may be acyanotic if large VSD provides adequate mixing</li> <li>Young adulthood: Systemic RV tolerates hemodynamic load reasonably well</li> <li>Progressive dysfunction: 25\u201330-year-old patients often show declining RV function and increasing valve regurgitation</li> <li>Complications: Arrhythmias, heart failure, endocarditis risk</li> </ul>"},{"location":"congenital/cctga/#post-surgical-if-prior-intervention","title":"Post-Surgical (if prior intervention)","text":"<ul> <li>VSD closure if hemodynamically significant</li> <li>Pulmonary stenosis relief or RV outflow tract procedures</li> <li>Double switch operation (rare, very young patients): Restores LV as systemic ventricle</li> <li>Atrial switch + arterial switch (historical, less common now)</li> </ul>"},{"location":"congenital/cctga/#associated-findings","title":"Associated Findings","text":""},{"location":"congenital/cctga/#cardiac","title":"Cardiac","text":"<ul> <li>Conduction abnormalities: ~50% have heart block (related to abnormal AV nodal location)</li> <li>Arrhythmias: Atrial flutter/fibrillation common in older patients; pre-excitation (WPW) possible</li> <li>Endocarditis: Increased risk with VSD and valve abnormalities</li> </ul>"},{"location":"congenital/cctga/#extracardiac","title":"Extracardiac","text":"<ul> <li>Heterotaxy: Assess splenic position, sidedness of vena cava, lung airway anatomy</li> <li>Cardiac malposition (dextrocardia possible but rare in ccTGA)</li> <li>Associated syndromes: Down syndrome (Trisomy 21)</li> </ul>"},{"location":"congenital/cctga/#prognosis-and-management","title":"Prognosis and Management","text":""},{"location":"congenital/cctga/#natural-history","title":"Natural History","text":"<ul> <li>Infants and children often cyanotic; cyanosis may improve with growth or spontaneous closure of PDA</li> <li>Adolescents and young adults generally stable if uncomplicated</li> <li>Systemic RV dysfunction typically emerges in 3rd\u20134th decade</li> <li>Survival to adulthood without intervention is possible but long-term outcome depends on degree of associated lesions</li> </ul>"},{"location":"congenital/cctga/#management-considerations","title":"Management Considerations","text":"<ol> <li>Asymptomatic uncomplicated ccTGA with large VSD:</li> <li>May not require early intervention</li> <li> <p>Serial follow-up for RV size and function</p> </li> <li> <p>Restrictive VSD or cyanosis:</p> </li> <li>Balloon atrial septostomy (Rashkind) in infancy if inadequate mixing</li> <li> <p>VSD closure if hemodynamically significant</p> </li> <li> <p>Progressive RV dysfunction, valve regurgitation:</p> </li> <li>Afterload reduction therapy</li> <li>Consider double switch operation (controversial; best in young children)</li> <li> <p>Heart transplantation if end-stage</p> </li> <li> <p>Endocarditis prophylaxis:</p> </li> <li>Recommended for patients with VSD or valve abnormalities</li> </ol>"},{"location":"congenital/cctga/#key-teaching-points","title":"Key Teaching Points","text":"<p>\u2713 Two discordances = concordant physiology: Abnormal anatomy delivers blood appropriately but with systemic RV at risk \u2713 Mirror-image coronaries: Right coronary from left sinus (anterior) \u2014 critical for surgery \u2713 Systemic RV dysfunction: The limiting factor; emerges decades into life \u2713 High association with VSD, valve regurgitation, subaortic stenosis, and conduction abnormalities \u2713 Heterotaxy is frequent: Always assess situs and splenic position  </p>"},{"location":"congenital/cctga/#references-further-reading","title":"References &amp; Further Reading","text":"<ul> <li>Anderson RH, Baker EJ, Macartney FJ, et al. Paediatric cardiology. 3rd ed. Churchill Livingstone; 2010.</li> <li>Fathallah A, Felfli M, Albabtain A. Congenitally corrected transposition of the great arteries: a review of imaging findings and management strategies. Insights Imaging. 2020;11(1):122.</li> <li>Presbitero P, Saracino A, Somerville J. Congenitally corrected transposition of the great arteries. Am J Cardiol. 1995;76(3):153\u2013157.</li> </ul>"},{"location":"congenital/coa/","title":"Coarctation of the Aorta (CoA)","text":""},{"location":"congenital/coa/#anatomy","title":"Anatomy","text":"<p>Location: Narrowing of descending thoracic aorta, typically at the isthmus (just distal to left subclavian artery takeoff).</p> <p>Classification: - Preductal: Proximal to ductus arteriosus (rare; associated with hypoplastic left heart features) - Juxtaductal: At the level of ductus arteriosus (most common) - Postductal: Distal to ductus arteriosus</p>"},{"location":"congenital/coa/#hemodynamics","title":"Hemodynamics","text":"<ul> <li>Native anatomy: Narrowing causes proximal hypertension and reduced distal flow</li> <li>Collateral development: Intercostal, internal mammary vessels enlarge to decompress proximal aorta (can be prominent on imaging)</li> <li>Gradient: By PC velocity and Bernoulli equation</li> <li>Note: PC likely underestimates true gradient if significant collateral decompression is present</li> </ul>"},{"location":"congenital/coa/#cmr-imaging","title":"CMR Imaging","text":"<p>Morphology: - Axial dark blood imaging to visualize narrowing - Sagittal reconstructions to measure coarctation shelf - Note bicuspid aortic valve (present in ~50% of CoA)</p> <p>Flow assessment: - PC velocity at narrowest point   - Mild: &lt;2 m/s   - Moderate\u2013severe: &gt;2 m/s (Bernoulli: \u0394P = 4V\u00b2 = &gt;16 mmHg) - Compare proximal (ascending aorta) vs distal (descending aorta) flow</p> <p>Aortic root/ascending aorta: - Measure diameter at annulus, sinuses, sinotubular junction - Aortic root dilation common and progressive</p>"},{"location":"congenital/coa/#associated-findings","title":"Associated Findings","text":"<ul> <li>Bicuspid aortic valve: ~50% association; assess for stenosis or regurgitation</li> <li>Hypoplastic features: Narrowed aortic arch, underdeveloped descending thoracic aorta</li> <li>Turner syndrome: Increased CoA coexistence; screen for other cardiac/renal abnormalities</li> <li>Mitral valve abnormalities: Hypoplastic MV</li> <li>Ventricular septal defect: May coexist</li> </ul>"},{"location":"congenital/coa/#post-repair-complications","title":"Post-repair Complications","text":""},{"location":"congenital/coa/#surgical-repair-end-to-end-anastomosis-or-patch","title":"Surgical Repair (End-to-end anastomosis or patch)","text":"<ul> <li>Re-coarctation: Narrowing at repair site; occurs in 10\u201320% over years</li> <li>Aneurysm: Especially at Dacron patch sites; risk of rupture</li> <li>Aortic root changes: Continued progression of dilation despite successful repair</li> </ul>"},{"location":"congenital/coa/#balloon-expandable-stent-placement","title":"Balloon Expandable Stent Placement","text":"<ul> <li>Effective for postoperative re-coarctation</li> <li>Complications: Residual narrowing, aortic wall perforation, stent fracture</li> </ul>"},{"location":"congenital/coa/#hypertension-management","title":"Hypertension Management","text":"<ul> <li>Pre-repair: Often severe hypertension; medications required</li> <li>Post-repair: Hypertension may persist even after successful repair due to aortic stiffness</li> <li>Long-term monitoring essential (home BP checks, antihypertensive therapy)</li> </ul>"},{"location":"congenital/coa/#imaging-follow-up","title":"Imaging Follow-up","text":"<p>Serial imaging (CMR or CT) to assess: - Residual narrowing and peak velocity - Aortic root growth - Development of collaterals (if re-narrowing) - Associated lesion progression (e.g., aortic stenosis)</p>"},{"location":"congenital/dorv/","title":"Double Outlet Right Ventricle (DORV)","text":""},{"location":"congenital/dorv/#overview","title":"Overview","text":"<p>Double Outlet Right Ventricle (DORV) is a rare but complex lesion in which both the aorta and pulmonary artery arise predominantly or entirely from the morphologic right ventricle. The morphologic left ventricle contributes minimal or no blood to the great arteries. Communication between the right and left ventricles via a ventricular septal defect (VSD) is essential for survival, as it provides the only outlet for left ventricular blood.</p>"},{"location":"congenital/dorv/#key-features","title":"Key Features","text":"<ul> <li>Both great arteries originate from the RV: Usually &gt;50% of each artery arises from the RV</li> <li>Obligatory VSD: Systemic-to-pulmonary connection essential for survival</li> <li>Variable anatomy: Great artery relationships (anterior\u2013posterior, side-by-side, right-to-left) and VSD position vary widely</li> <li>Associated lesions: Heterotaxy, pulmonary stenosis, hypoplastic pulmonary arteries, other CHD</li> <li>Complex surgical anatomy: Repair strategy depends on VSD location relative to great arteries</li> </ul>"},{"location":"congenital/dorv/#segmental-anatomy","title":"Segmental Anatomy","text":""},{"location":"congenital/dorv/#situs-and-orientation","title":"Situs and Orientation","text":"<ul> <li>Usually situs solitus but heterotaxy is common (~30% of DORV patients)</li> <li>Levocardia typical, but various cardiac positions possible</li> <li>Evaluate splenic and visceral situs carefully</li> </ul>"},{"location":"congenital/dorv/#venous-drainage","title":"Venous Drainage","text":"<ul> <li>Systemic venous return (SVC + IVC) typically drains to right atrium (normal)</li> <li>Pulmonary venous return typically drains to left atrium (normal)</li> <li>Anomalous pulmonary venous return possible; assess all four PVs</li> </ul>"},{"location":"congenital/dorv/#atrioventricular-connections","title":"Atrioventricular Connections","text":"<ul> <li>Concordant: Right atrium \u2192 tricuspid valve \u2192 morphologic right ventricle</li> <li>Concordant: Left atrium \u2192 mitral valve \u2192 morphologic left ventricle</li> <li>AV connections are normal; abnormality is entirely at ventriculoarterial level</li> </ul>"},{"location":"congenital/dorv/#ventricles","title":"Ventricles","text":"<ul> <li>Morphologic right ventricle (dominant chamber):</li> <li>Enlarged, receives blood from both atria (via tricuspid valve) and from LV (via VSD)</li> <li>Gives rise to both aorta and pulmonary artery</li> <li> <p>Hypertrophied walls</p> </li> <li> <p>Morphologic left ventricle (hypoplastic, \"unwedged\"):</p> </li> <li>Small chamber, \"wedged\" between aortic root and ventricular septum</li> <li>No outlet to great arteries (or minimal contribution)</li> <li> <p>Blood escapes via VSD to RV</p> </li> <li> <p>Ventricular septal defect (obligatory):</p> </li> <li>Communication between RV and LV essential for pulmonary and systemic blood flow</li> <li>VSD classification by position:<ul> <li>Subarterial (doubly committed): Directly under both PA and aorta</li> <li>Perimembranous with RV outlet extension: Under both arteries but via membranous defect</li> <li>Perimembranous with inlet extension: Rare, further from arteries</li> <li>Remote VSD: Far from both great arteries; uncommon in DORV</li> </ul> </li> </ul>"},{"location":"congenital/dorv/#ventriculoarterial-connections-abnormalboth-from-rv","title":"Ventriculoarterial Connections (Abnormal\u2014Both from RV)","text":"<ul> <li>Aorta arises from RV: Usually with variable degree of override from LV (typically &gt;50% arises from RV)</li> <li>Pulmonary artery arises from RV: Variable position and take-off relative to aorta</li> <li>Relationship of great arteries:</li> <li>Anterior\u2013posterior: Aorta anterior to PA, or vice versa (most common)</li> <li>Side-by-side: Aorta to the right of PA</li> <li>PA appears to override VSD: Rare but possible (mimics PA-concordant physiology)</li> </ul>"},{"location":"congenital/dorv/#coronary-arteries","title":"Coronary Arteries","text":"<ul> <li>Coronary ostia typically arise from expected sinuses despite abnormal great artery positions</li> <li>May be displaced or abnormally positioned in ~10\u201315% of cases</li> <li>Coronary assessment critical before surgical planning to avoid inadvertent injury during arterial transposition</li> </ul>"},{"location":"congenital/dorv/#aorta","title":"Aorta","text":"<ul> <li>Arises predominantly from morphologic right ventricle</li> <li>Position variable: anterior, posterior, or side-by-side relative to pulmonary artery</li> <li>Systemic output dependent on RV contractility and VSD flow dynamics</li> <li>Monitor for:</li> <li>Aortic regurgitation</li> <li>Aortic root dilation (variable)</li> </ul>"},{"location":"congenital/dorv/#pulmonary-arteries","title":"Pulmonary Arteries","text":"<ul> <li>Arises predominantly from morphologic right ventricle</li> <li>Often hypoplastic, especially if subaortic stenosis develops</li> <li>Pulmonary blood flow depends on:</li> <li>RV-to-PA flow (not LV-to-PA, as LV has no PA outlet)</li> <li>VSD size and restrictiveness (if small, limits pulmonary flow)</li> <li>Degree of pulmonary stenosis if present</li> </ul>"},{"location":"congenital/dorv/#dorv-classification-surgical-perspective","title":"DORV Classification (Surgical Perspective)","text":"<p>The surgical approach depends on VSD location relative to the great arteries and aortic position:</p> Type VSD Position Aorta Position Physiology Surgical Approach Subarterial VSD (Taussig-Bing) Under both PA and aorta Anterior to PA; PA more posterior Similar to TGA (cyanotic) PA switch (Rastelli-like) or arterial switch Perimembranous with anterior extension Under aorta primarily Usually anterior-left L-R shunt if no LVOTO VSD closure \u00b1 aortic repositioning; Rastelli if needed Perimembranous with posterior extension Under PA primarily Usually posterior L-R shunt; similar to VSD physiology VSD closure \u00b1 PA outflow procedures Remote VSD Far from both arteries Variable Creates challenges Complex repair; may need conduit"},{"location":"congenital/dorv/#hemodynamics-and-associated-lesions","title":"Hemodynamics and Associated Lesions","text":""},{"location":"congenital/dorv/#degree-of-cyanosis","title":"Degree of Cyanosis","text":"<p>Depends on:</p> <ol> <li>VSD size: </li> <li>Small VSD \u2192 Limited LV output to RV \u2192 Cyanosis</li> <li> <p>Large VSD \u2192 Better mixing \u2192 Less cyanosis</p> </li> <li> <p>Relative positions of aorta and PA:</p> </li> <li>If aorta favors RV inlet \u2192 Better systemic output \u2192 Less cyanosis</li> <li> <p>If aorta is \"unwedged\" and primarily receives RV inlet blood \u2192 Better systemic flow</p> </li> <li> <p>Associated pulmonary stenosis:</p> </li> <li>Decreases pulmonary flow \u2192 Increases cyanosis</li> </ol>"},{"location":"congenital/dorv/#associated-lesions","title":"Associated Lesions","text":"Lesion Frequency Significance Pulmonary stenosis 30\u201350% Restricts pulmonary flow; worsens cyanosis AV valve abnormalities 20\u201340% TV or MV dysplasia/regurgitation Heterotaxy ~30% Situs inversus, asplenia, polysplenia, IVC anomalies Left AV valve regurgitation 10\u201320% Volume overload if present Hypoplastic pulmonary arteries 20\u201330% Limits surgical options Aortic regurgitation 10\u201320% From VSD proximity to aortic valve CoA or aortic stenosis 5\u201310% Additional LVOTO"},{"location":"congenital/dorv/#cmr-imaging-pearls","title":"CMR Imaging Pearls","text":""},{"location":"congenital/dorv/#morphologic-assessment","title":"Morphologic Assessment","text":"<ol> <li>Confirm both arteries from RV:</li> <li>Trace aorta and PA from their origins</li> <li>Identify RV insertion points</li> <li> <p>Confirm LV does not give rise to either vessel</p> </li> <li> <p>Identify and characterize VSD:</p> </li> <li>Location relative to great arteries (subarterial, perimembranous, remote)</li> <li>Size and restrictiveness</li> <li> <p>Relationships to aortic and pulmonary valves</p> </li> <li> <p>Define great artery relationship:</p> </li> <li>Anterior\u2013posterior, side-by-side, or other</li> <li> <p>Aortic position relative to pulmonary artery crucial for surgical planning</p> </li> <li> <p>Ventricular chamber size and function:</p> </li> <li>RV is dominant; measure volumes and ejection fraction</li> <li>LV is hypoplastic; assess degree of hypoplasia</li> <li> <p>Measure relative chamber sizes</p> </li> <li> <p>Coronary artery anatomy:</p> </li> <li>Identify origins and course of coronary arteries</li> <li>Exclude anomalous coronaries (e.g., left coronary from right sinus)</li> <li>May require dedicated coronary CMR</li> </ol>"},{"location":"congenital/dorv/#flow-imaging","title":"Flow Imaging","text":"<ul> <li>4D flow or 2D PC through great arteries:</li> <li>Quantify aortic and pulmonary artery flows</li> <li>Assess VSD shunt magnitude (left-to-right typically predominates)</li> <li>Measure pulmonary stenosis gradient if present</li> <li> <p>Measure aortic regurgitation if suspected</p> </li> <li> <p>PC through VSD (if imaging plane can capture):</p> </li> <li>Direction and magnitude of shunt</li> <li>Peak velocity indicating restrictiveness</li> </ul>"},{"location":"congenital/dorv/#lge-assessment","title":"LGE Assessment","text":"<ul> <li>Usually minimal LGE unless associated myocarditis or fibrosis</li> <li>Assess for scar or replacement fibrosis related to complex hemodynamics</li> </ul>"},{"location":"congenital/dorv/#natural-history-and-clinical-presentation","title":"Natural History and Clinical Presentation","text":""},{"location":"congenital/dorv/#neonates-and-infants","title":"Neonates and Infants","text":"<ul> <li>Cyanosis: Degree varies based on anatomy</li> <li>Prostaglandin E1 (PGE1): Maintains ductus arteriosus to improve pulmonary blood flow if critical cyanosis</li> <li>Balloon atrial septostomy (Rashkind): May improve mixing if needed</li> <li>Surgical intervention required in first weeks to months</li> </ul>"},{"location":"congenital/dorv/#surgical-timing-and-strategy","title":"Surgical Timing and Strategy","text":"<p>Goals of repair: - Separate systemic and pulmonary circulations - Restore aorta and PA to their appropriate ventricles (if possible) - Alleviate LVOTO and pulmonary stenosis</p> <p>Common approaches:</p> <ol> <li>Rastelli operation:</li> <li>For subarterial VSD or other configurations</li> <li>VSD closure redirects LV blood to aorta</li> <li>Conduit placed from RV to PA</li> <li> <p>Conduit requires future replacements as child grows</p> </li> <li> <p>Arterial switch + VSD closure:</p> </li> <li>For \"Taussig-Bing\" anatomy</li> <li> <p>Rearrange great arteries + close VSD</p> </li> <li> <p>VSD closure + pulmonary artery transfer (less common):</p> </li> <li>If anatomy permits</li> </ol>"},{"location":"congenital/dorv/#long-term-outcomes","title":"Long-term Outcomes","text":"<ul> <li>Rastelli with conduit: Multiple re-operations needed as child grows</li> <li>Up to 1 in 3 patients may need heart transplantation eventually</li> <li>LV hypoplasia may limit ability to restore normal circulation in some cases</li> <li>Excellent immediate outcomes with good surgical technique, but long-term follow-up essential</li> </ul>"},{"location":"congenital/dorv/#associated-findings-and-syndromes","title":"Associated Findings and Syndromes","text":""},{"location":"congenital/dorv/#cardiac","title":"Cardiac","text":"<ul> <li>Associated CHD: Very high incidence of additional anomalies</li> <li>Heterotaxy spectrum: Up to 30% have heterotaxy, asplenia, or polysplenia</li> <li>Coronary anomalies: 10\u201315% have abnormal coronary origins</li> </ul>"},{"location":"congenital/dorv/#extracardiac","title":"Extracardiac","text":"<ul> <li>Heterotaxy syndrome: Howell-Jolly bodies on blood smear (asplenia); increased risk of overwhelming sepsis</li> <li>Syndromes: Digeorge/22q11 deletion, visceral heterotaxy associations</li> <li>Gastrointestinal: Malrotation, asplenia/polysplenia, heterotaxy</li> </ul>"},{"location":"congenital/dorv/#prognosis-and-long-term-management","title":"Prognosis and Long-Term Management","text":""},{"location":"congenital/dorv/#survival","title":"Survival","text":"<ul> <li>Without intervention: Inviable; affected infants die in first days to weeks</li> <li>With surgical repair: </li> <li>Early mortality ~5\u201310% (depends on complexity)</li> <li>10-year survival ~70\u201380%</li> <li>Late mortality mainly from RV dysfunction, conduit failure, or need for transplantation</li> </ul>"},{"location":"congenital/dorv/#follow-up-essentials","title":"Follow-up Essentials","text":"<ol> <li>Serial RV size and function assessment (echocardiography/CMR)</li> <li>Conduit assessment (if Rastelli): Echocardiography for stenosis and regurgitation</li> <li>Arrhythmia monitoring: Post-operative incision sites predispose to reentrant circuits</li> <li>Coronary status: Late coronary compression or ostial anomalies</li> <li>Antibiotic prophylaxis for endocarditis (lifelong, even after successful repair)</li> </ol>"},{"location":"congenital/dorv/#key-teaching-points","title":"Key Teaching Points","text":"<p>\u2713 Both great arteries from RV: Obligate VSD provides left ventricular outlet \u2713 VSD anatomy determines surgical approach: Subarterial, perimembranous, or remote affects repair strategy \u2713 Rastelli operation: Common strategy; requires multiple conduit replacements \u2713 Heterotaxy frequent: ~30% have asplenia/polysplenia; varicella vaccination important \u2713 Complex imaging: Careful segmental analysis and coronary assessment essential pre-operatively  </p>"},{"location":"congenital/dorv/#references-further-reading","title":"References &amp; Further Reading","text":"<ul> <li>Anderson RH, Becker AE, Freedom RM, et al. Sequential segmental analysis of congenital heart disease. Pediatr Cardiol. 1984;5(3):197\u2013211.</li> <li>Loffredo CA, Chokkalingam A, Sill AM, et al. Epidemiology of down and other chromosomal abnormalities. Birth Defects Res A Clin Mol Teratol. 2012;94(7):499\u2013506.</li> <li>Mercer-Rosa L, Yang W, Kutty S, et al. Hemodynamics and myocardial deformation in double outlet right ventricle. Am J Cardiol. 2015;115(5):598\u2013603.</li> <li>Mori M, Nakaoka H, Saikietal T. Rare stenotic phenotype of double outlet right ventricle. Congenit Heart Dis. 2014;9(2):142\u2013151.</li> <li>Van Praagh R, David I. What is double outlet right ventricle? Circulation. 1982;66(Suppl I):I-17.</li> </ul>"},{"location":"congenital/ebstein/","title":"Ebstein Anomaly","text":""},{"location":"congenital/ebstein/#anatomy","title":"Anatomy","text":"<p>Hallmark: Apical displacement of the septal and posterior leaflets of the tricuspid valve from normal insertion at the annulus.</p> <p>Diagnostic criterion (echo): Displacement \u22658 mm/m\u00b2 (body surface area) below the mitral valve annulus level</p> <p>Key structural feature: - \"Atrialized\" RV: Portion of RV (from TV insertion to AV junction) is thin-walled and contractually incompetent; functions as part of RA - Functional RV: Small chamber; often hypertrophic and restricted</p>"},{"location":"congenital/ebstein/#physiology","title":"Physiology","text":"<ul> <li>Tricuspid regurgitation: Almost universal</li> <li>Leaflets are dysplastic and may not coapt properly</li> <li> <p>Severity varies: mild to severe</p> </li> <li> <p>Right-to-left shunting: ASD or patent foramen ovale present in ~70% of cases</p> </li> <li>Permits R\u2192L shunting if RA pressure is elevated \u2192 cyanosis</li> <li> <p>Cyanosis typically mild (SaO\u2082 often 90\u201395%)</p> </li> <li> <p>Atrial arrhythmias: Accessory pathways (WPW syndrome) in ~25% of Ebstein patients</p> </li> <li>Risk of accessory pathway-mediated tachycardia</li> </ul>"},{"location":"congenital/ebstein/#cmr-assessment","title":"CMR Assessment","text":""},{"location":"congenital/ebstein/#ventricular-volumes-and-function","title":"Ventricular Volumes and Function","text":"<ul> <li>Measure functional RV volume (exclude atrialized portion from RV cavity)</li> <li>Delineate atrialization boundary by cine</li> <li>RV EF often reduced</li> <li> <p>Severe dysfunction may require intervention</p> </li> <li> <p>LV volume and function: Secondary effects from RV dilation (septal bulge into LV)</p> </li> </ul>"},{"location":"congenital/ebstein/#tricuspid-regurgitation","title":"Tricuspid Regurgitation","text":"<ul> <li>Severity assessment: 4D flow quantifies regurgitant volume and fraction</li> <li>Pathophysiology: Dysplastic TV with malcoaptation; may have prolapse of leaflet</li> </ul>"},{"location":"congenital/ebstein/#associated-findings","title":"Associated Findings","text":"<ul> <li>ASD/PFO: Screen for right-to-left shunt on 4D flow</li> <li>Accessory pathway: Consider electrophysiology referral if WPW pattern on ECG</li> <li>Other structural abnormalities: LVOTO (left ventricular outflow obstruction), pulmonary stenosis</li> </ul>"},{"location":"congenital/ebstein/#atrial-enlargement","title":"Atrial Enlargement","text":"<ul> <li>RA dilation: Often marked</li> <li>LA size: Usually normal unless secondary LA dilation from TR</li> </ul>"},{"location":"congenital/ebstein/#clinical-considerations","title":"Clinical Considerations","text":""},{"location":"congenital/ebstein/#indications-for-surgery","title":"Indications for Surgery","text":"<ul> <li>Symptomatic cyanosis: SaO\u2082 &lt;90%</li> <li>Severe RV dysfunction: RV EF &lt;35% or significant dilation</li> <li>Progressive arrhythmias: Refractory to medical management</li> <li>Paradoxical embolism risk: Large PFO/ASD with cyanosis</li> </ul> <p>Surgical options: - TV repair (cone procedure) or replacement - ASD closure (to reduce R\u2192L shunt) - Arrhythmia management (if WPW)</p>"},{"location":"congenital/ebstein/#medical-management","title":"Medical Management","text":"<ul> <li>Antiarrhythmics for accessory pathway-mediated arrhythmias</li> <li>Diuretics for right heart failure</li> <li>Anticoagulation if atrial fibrillation develops</li> </ul>"},{"location":"congenital/ebstein/#imaging-follow-up","title":"Imaging Follow-up","text":"<p>Serial CMR to assess: - RV volume and function trajectory - TR progression - LA/RA size changes - Development of arrhythmias or symptoms requiring intervention</p>"},{"location":"congenital/fontan/","title":"Fontan Circulation","text":""},{"location":"congenital/fontan/#physiology","title":"Physiology","text":"<p>Goal: Eliminate the subpulmonary ventricle; direct systemic venous return directly to pulmonary arteries (passive flow).</p> <p>Types: - Atriopulmonary connection: RA to PA (older, rarely used now) - Total cavopulmonary connection (TCPC): IVC and SVC \u2192 PA (standard modern approach, often with fenestration)</p> <p>Staged approach: 1. Norwood procedure (if needed): Restructure aorta; RV-to-PA shunt 2. Glenn procedure (Stage 2): SVC to PA (hemi-Fontan) 3. Fontan procedure (Stage 3): IVC to PA, completing TCPC</p>"},{"location":"congenital/fontan/#cmr-assessment","title":"CMR Assessment","text":""},{"location":"congenital/fontan/#critical-parameters","title":"Critical Parameters","text":"<ul> <li>Single (systemic) ventricle EF and EDVi: Primary prognostic marker</li> <li>EF &gt;40% is favorable</li> <li> <p>Progressive decline predicts worse outcomes</p> </li> <li> <p>Fontan conduit flow: Total superior + inferior systemic venous return</p> </li> <li> <p>Compare to pulmonary artery flow to assess collateral flow</p> </li> <li> <p>Pulmonary artery flow distribution:</p> </li> <li>LPA flow</li> <li>RPA flow</li> <li> <p>LPA:RPA ratio (aim for \u22650.4 for balanced distribution)</p> </li> <li> <p>Pulmonary collateral flow: Calculated as (Total PA flow) \u2212 (Fontan conduit flow)</p> </li> <li>Normal: &lt;20% of systemic cardiac output</li> <li> <p>Significant collaterals (&gt;20%): Bypass pulmonary vascular bed, reduce PA flow</p> </li> <li> <p>Systemic venous collaterals: Bypasses Fontan circuit</p> </li> <li>Porto-systemic collaterals (suggest elevated IVC pressure)</li> <li>Scan to include abdomen/inguinal region</li> </ul>"},{"location":"congenital/fontan/#av-valve-function","title":"AV Valve Function","text":"<ul> <li>Atrioventricular valve regurgitation: Common and progressive</li> <li>Quantify regurgitant fraction by 4D flow</li> <li>Severe regurgitation increases risk of failure</li> </ul>"},{"location":"congenital/fontan/#additional-assessments","title":"Additional Assessments","text":"<ul> <li>Ventricular function and fibrosis: LGE helps identify early remodeling</li> <li>Pulmonary vascular resistance markers: Elevated Fontan pressure correlates with elevated collateral flow</li> <li>IVC flow pattern: Retrograde flow suggests elevated IVC pressure (poor prognosis marker)</li> </ul>"},{"location":"congenital/fontan/#fenestration","title":"Fenestration","text":"<p>Intentional R\u2192L shunt: Small connection between Fontan conduit and RA (or fenestration in baffle). - Allows decompression of elevated venous pressure - Trade-off: Mild cyanosis (lower SaO\u2082, typically 92\u201395%) - CMR findings: Expect Qp:Qs &lt;1.0; visible shunt on 4D flow</p>"},{"location":"congenital/fontan/#long-term-complications","title":"Long-term Complications","text":"<ul> <li>Protein-losing enteropathy (PLE): Albumin loss from intestinal lymphatic obstruction</li> <li>Risk factors: Low EF, elevated Fontan pressure, severe collaterals</li> <li>Atrial arrhythmias: Intra-atrial reentrant tachycardia (IART) common</li> <li>Thromboembolic risk: Consider anticoagulation if persistent atrial fibrillation</li> <li>Progressive ventricular dysfunction: EF decline over years to decades</li> <li>Hepatic cirrhosis: Chronic venous congestion \u2192 fibrosis</li> </ul>"},{"location":"congenital/fontan/#imaging-follow-up","title":"Imaging Follow-up","text":"<p>Serial CMR (typically yearly in young children, varies by stability) to track: - Ventricular volume and function - Growth of collateral vessels - Progression of valve disease - Signs of protein-losing enteropathy</p>"},{"location":"congenital/tga/","title":"Transposition of the Great Arteries","text":""},{"location":"congenital/tga/#d-tga-post-arterial-switch-jatene-procedure","title":"D-TGA: Post-Arterial Switch (Jatene Procedure)","text":"<p>Physiology: Aorta arises from right ventricle, pulmonary artery from left ventricle. Arterial switch repositions great vessels to anatomically correct positions.</p>"},{"location":"congenital/tga/#post-repair-assessment","title":"Post-repair Assessment","text":"<p>Neo-aortic root dilation: The native pulmonary artery (now functioning as aorta) commonly dilates. - Measure at annulus, sinuses of Valsalva, sinotubular junction - Progressive dilation may warrant intervention</p> <p>Neo-pulmonary stenosis (RVOTO):  - Right ventricle now pumps to pulmonary artery (behind aorta) - Narrowing can develop at anastomotic site - Assess by PC velocity; use Bernoulli equation</p> <p>Coronary anatomy:  - Native coronaries are re-implanted into neoaortic root - Assess for ostial stenosis (best by coronary CT or invasive catheterization)</p> <p>Ventricular function: - LV is now systemic ventricle (normal location) - May show functional decline if post-ischemic complications</p>"},{"location":"congenital/tga/#d-tga-post-atrial-switch-mustardsenning-procedure","title":"D-TGA: Post-Atrial Switch (Mustard/Senning Procedure)","text":"<p>Note: This is older operative approach; fewer cases in modern practice but important for long-term follow-up</p> <p>Physiology: Intra-atrial baffle redirects inferior/superior vena cava to mitral valve and pulmonary veins to tricuspid valve. Systemic RV: RV remains systemic ventricle; bears pressure load chronically.</p>"},{"location":"congenital/tga/#long-term-assessment-cmr-focus","title":"Long-term Assessment (CMR focus)","text":"<p>Systemic RV volume and function: - RV EF and EDV critical prognostic markers - EF &lt;40% indicates significant dysfunction - Progressive EF decline predicts worse long-term outcomes</p> <p>Baffle complications: - SVC baffle stenosis (obstruction of superior vena cava pathway) - IVC baffle stenosis (obstruction of inferior vena cava pathway) - Baffle leak: R\u2192L shunting allows deoxygenated blood to systemic circulation</p> <p>AV valve regurgitation:  - Systemic (tricuspid) regurgitation from chronic RV dilation</p> <p>Arrhythmias: High incidence of atrial fibrillation and flutter due to stretched atria</p>"},{"location":"congenital/tga/#monitoring","title":"Monitoring","text":"<p>Long-term follow-up includes echocardiography and periodic CMR to assess RV decline and baffle integrity.</p>"},{"location":"congenital/tof/","title":"Tetralogy of Fallot (TOF)","text":"<p>Four components: VSD + overriding aorta + RVOTO + RVH</p>"},{"location":"congenital/tof/#pre-repair","title":"Pre-repair","text":"<p>Early diagnosis via fetal echo or postnatal echocardiography. Surgical candidates typically have adequate pulmonary arteries and left-to-right shunting with cyanosis.</p>"},{"location":"congenital/tof/#post-repair-assessment","title":"Post-repair Assessment","text":""},{"location":"congenital/tof/#cmr-evaluation","title":"CMR Evaluation","text":"Measurement Normal Concern RV EDVi 80\u2013110 mL/m\u00b2 &gt;160 suggests progressive dilation RV EF &gt;45% &lt;40% = significant dysfunction Pulmonary RF &lt;20% &gt;40% = severe PR LV EF &gt;55% QRS duration &lt;160 ms &gt;180 ms = arrhythmia risk"},{"location":"congenital/tof/#key-findings","title":"Key Findings","text":"<ul> <li>Pulmonary regurgitation: Measure PR by 4D flow at main PA. Progressive PR leads to RV dilation; major reason for pulmonary valve replacement (PVR)</li> <li>Residual RVOTO: Measure by PC velocity at site of narrowing (often infundibular). Use Bernoulli equation</li> <li>RPA stenosis: Common post-repair. Compare LPA:RPA flow ratios</li> <li>Aortic root dilation: Common sequelae. Measure at annulus, sinuses of Valsalva, sinotubular junction, ascending aorta</li> </ul>"},{"location":"congenital/tof/#pvr-timing","title":"PVR Timing","text":"<p>CMR RV volumes guide PVR indication. Most centers use: - RVEDVi &gt;150\u2013160 mL/m\u00b2 AND/OR RF &gt;40% as thresholds for consideration of intervention</p>"},{"location":"congenital/tof/#complications","title":"Complications","text":"<ul> <li>Arrhythmias (sustained VT risk if QRS &gt;180 ms)</li> <li>Aortic root aneurysm</li> <li>Left ventricular dysfunction (late finding)</li> <li>Sudden cardiac death risk in untreated severe RV dilation</li> </ul>"},{"location":"congenital/vsd/","title":"Ventricular Septal Defect (VSD)","text":""},{"location":"congenital/vsd/#classification","title":"Classification","text":"Type Prevalence Location Features Perimembranous 80% Membranous septum Most common; can extend into inlet or outlet Muscular 5\u201320% Muscular septum May close spontaneously; varies by location Outlet (Supracristal) 5\u20138% Above pulmonary and aortic valves Risk of aortic regurgitation Inlet (Endocardial cushion) 8\u201310% Below AV valves Part of AVSD spectrum"},{"location":"congenital/vsd/#hemodynamic-significance","title":"Hemodynamic Significance","text":"<p>Shunt magnitude from CMR 4D Flow:</p> Qp:Qs Category Clinical Significance &lt;1.5 Small Hemodynamically insignificant; unlikely to need closure 1.5\u20132.0 Moderate May warrant monitoring; closure considered if progressive &gt;2.0 Large Significant L\u2192R shunt; closure indicated"},{"location":"congenital/vsd/#special-considerations","title":"Special Considerations","text":"<p>Eisenmenger Syndrome: - Reversed shunt (Qp:Qs &lt;1.0) and cyanosis from fixed pulmonary hypertension - Irreversible; closure contraindicated (would cause systemic RV afterload crisis) - Managed medically with pulmonary vasodilators</p> <p>Aortic regurgitation:  - Particularly with outlet/supracristal defects - Assess severity on cine imaging and by 4D flow</p> <p>Associated lesions: - Concomitant ASD in primum type - Pulmonary stenosis (cyanotic form)</p>"},{"location":"congenital/vsd/#cmr-assessment","title":"CMR Assessment","text":"<ul> <li>Defect location and size: Dark blood imaging (HASTE/TSE) axial stack</li> <li>Flow calculation: 4D flow at pulmonary artery and aorta for Qp:Qs</li> <li>Ventricular function: SAX cine stack of each ventricle</li> <li>LV dilation: Secondary to volume overload from L\u2192R shunt</li> </ul>"},{"location":"congenital/vsd/#closure-indications","title":"Closure Indications","text":"<ul> <li>Qp:Qs \u22651.5 (Class IIa)</li> <li>Qp:Qs &gt;2.0 in children (Class I)</li> <li>Pulmonary hypertension without reversal (Class I)</li> <li>Absolute contraindication: Eisenmenger physiology</li> </ul>"},{"location":"valves/","title":"Valve Grading Reference","text":"<p>Quick-reference severity grading for stenosis and regurgitation. Based on ACC/AHA and ASE guidelines.</p>"},{"location":"valves/#aortic-stenosis","title":"Aortic Stenosis","text":"Severity V<sub>max</sub> (m/s) Mean Gradient (mmHg) AVA (cm\u00b2) AVAi (cm\u00b2/m\u00b2) DI Mild 2.0\u20132.9 &lt;25 &gt;1.5 &gt;0.85 &gt;0.50 Moderate 3.0\u20133.9 25\u201339 1.0\u20131.5 0.60\u20130.85 0.25\u20130.50 Severe \u22654.0 \u226540 &lt;1.0 &lt;0.60 &lt;0.25 Very Severe \u22655.0 \u226560 &lt;0.6 \u2014 \u2014 <p>Low-Flow Low-Gradient AS</p> <ul> <li>Classic LFLG: EF &lt;50%, AVA &lt;1.0 cm\u00b2, mean gradient &lt;40 mmHg \u2192 dobutamine stress echo</li> <li>Paradoxical LFLG: EF \u226550%, AVA &lt;1.0 cm\u00b2, mean gradient &lt;40 mmHg, SVi &lt;35 mL/m\u00b2</li> <li>CT planimetry of valve area helpful in discordant cases</li> </ul> <p>AVA by continuity equation: \\(AVA = \\frac{CSA_{LVOT} \\times VTI_{LVOT}}{VTI_{AV}}\\)</p>"},{"location":"valves/#aortic-regurgitation-cmr-grading","title":"Aortic Regurgitation (CMR Grading)","text":"Severity RF (%) RVol (mL/beat) ERO (cm\u00b2) Vena Contracta (mm) Mild &lt;20 &lt;30 &lt;0.10 &lt;3 Moderate 20\u201339 30\u201359 0.10\u20130.29 3\u20136 Severe \u226540 \u226560 \u22650.30 &gt;6 <p>CMR AR Assessment</p> <p>Regurgitant fraction by 4D flow or 2D PC at the ascending aorta is the reference standard. RF \u226540% = severe. Also measure LV EDVi, ESVi, and EF.</p> <p>Aortic root dilation thresholds by CT/CMR:</p> Site Normal Consider surgery Aortic annulus &lt;25 mm/m\u00b2 \u2014 Sinus of Valsalva \u2642 &lt;40 mm, \u2640 &lt;36 mm \u2642 \u226555 mm (\u226550 mm in Marfan/bicuspid) Ascending aorta &lt;40 mm \u226555 mm (\u226545 mm in bicuspid)"},{"location":"valves/#mitral-stenosis","title":"Mitral Stenosis","text":"Severity MVA \u2014 PHT (cm\u00b2) MVA \u2014 Planimetry (cm\u00b2) Mean Gradient (mmHg) PASP (mmHg) Mild &gt;1.5 &gt;1.5 &lt;5 &lt;30 Moderate 1.0\u20131.5 1.0\u20131.5 5\u201310 30\u201350 Severe &lt;1.0 &lt;1.0 &gt;10 &gt;50 <p>Wilkins Score</p> <p>Echocardiographic score for MitraClip/PBMV suitability: leaflet mobility, thickening, calcification, subvalvular thickening. Score \u22648 = favorable for PBMV.</p>"},{"location":"valves/#mitral-regurgitation-cmr-grading","title":"Mitral Regurgitation (CMR Grading)","text":"Severity RF (%) RVol (mL/beat) ERO (cm\u00b2) Vena Contracta (mm) Mild &lt;20 &lt;30 &lt;0.20 &lt;3 Moderate 20\u201339 30\u201359 0.20\u20130.39 3\u20136.9 Severe \u226540 \u226560 \u22650.40 \u22657 <p>CMR method: LV stroke volume \u2212 Ao net forward flow = MR regurgitant volume. Or direct: PC at mitral valve (less reliable due to valve motion).</p>"},{"location":"valves/#tricuspid-regurgitation","title":"Tricuspid Regurgitation","text":"Severity Vena Contracta (mm) ERO (cm\u00b2) RVol (mL/beat) RVSP Mild &lt;3 &lt;0.20 &lt;30 Normal Moderate 3\u20136.9 0.20\u20130.39 30\u201344 Borderline Severe \u22657 \u22650.40 \u226545 Elevated Massive \u22659 \u22650.60 \u226560 \u2014 <p>RVSP estimation (TR jet): RVSP = 4 \u00d7 V\u00b2<sub>TR</sub> + RAP</p> <p>RAP estimate: 3 mmHg (normal IVC), 8 mmHg (borderline), 15 mmHg (dilated, non-collapsing IVC)</p>"},{"location":"valves/#pulmonary-regurgitation-cmr-grading","title":"Pulmonary Regurgitation (CMR Grading)","text":"Severity RF (%) RVol (mL/beat) Mild &lt;20 &lt;30 Moderate 20\u201339 30\u201344 Severe \u226540 \u226545 <p>Note</p> <p>CMR RF by 2D PC or 4D flow at the main PA is the clinical reference for PR severity, especially in post-TOF repair follow-up.</p>"},{"location":"valves/#pulmonary-stenosis","title":"Pulmonary Stenosis","text":"Severity V<sub>max</sub> (m/s) Peak Gradient (mmHg) Mild &lt;3.0 &lt;36 Moderate 3.0\u20134.0 36\u201364 Severe &gt;4.0 &gt;64"},{"location":"valves/tavr_tmvr/","title":"Device Planning CT","text":"<p>Planning CT reference for structural heart interventions. For scan protocols, see the Protocol Manager.</p>"},{"location":"valves/tavr_tmvr/#tavr-planning","title":"TAVR Planning","text":""},{"location":"valves/tavr_tmvr/#aortic-annulus-sizing","title":"Aortic Annulus Sizing","text":"<p>Measure perpendicular to the LVOT outflow axis (coronal oblique through the three hinge points of the aortic cusps).</p> Measurement How Notes Perimeter-derived D Trace annular perimeter \u2192 D = P/\u03c0 Primary sizing metric Area-derived D Trace annular area \u2192 D = 2\u221a(A/\u03c0) Cross-check Max / Min diameter Widest and narrowest annular diameters Assess eccentricity Annular area Planimetry Directly guides device selection LVOT D (3\u20135 mm below) Perpendicular measurement CoreValve sizing; LVOT obstruction risk"},{"location":"valves/tavr_tmvr/#root-measurements","title":"Root Measurements","text":"Level What Notes Sinus of Valsalva Max width (L/R/N cusps) Must accommodate device Sinotubular junction Width Narrow STJ constrains self-expanding devices Ascending aorta Max diameter Sheath compatibility; \u226545 mm = surgery threshold (bicuspid) Aortic root angle Aortoventricular angle Affects paravalvular leak risk and fluoroscopic projection"},{"location":"valves/tavr_tmvr/#coronary-occlusion-risk","title":"Coronary Occlusion Risk","text":"Coronary Height Risk &gt;15 mm Low risk 10\u201315 mm Moderate \u2014 consider BASILICA &lt;10 mm High \u2014 BASILICA or alternative approach <p>Bicuspid AV + TAVR</p> <p>Note raphe type (Sievers 0: no raphe; Sievers 1: 1 raphe; Sievers 2: 2 raphes). Eccentric or bulky calcification increases paravalvular leak and annular injury risk. RVSP model and calcium scoring helpful.</p>"},{"location":"valves/tavr_tmvr/#vascular-access","title":"Vascular Access","text":"Site Min Diameter Notes CFA (transfemoral) \u22655.5\u20136.0 mm (device-dependent) Preferred; assess with ilio-femoral run Iliacs \u22655.5 mm Look for severe tortuosity, heavy calcification Subclavian \u22656.0 mm (left preferred) Alternative if femoral unfavorable Transaortic Direct ascending access High-risk femoral anatomy Transapical Avoided when possible Only if all others unsuitable <p>Access angle: Iliofemoral angle &gt;90\u00b0 = higher risk of vascular complications.</p>"},{"location":"valves/tavr_tmvr/#tmvr-planning","title":"TMVR Planning","text":""},{"location":"valves/tavr_tmvr/#mitral-annulus-sizing","title":"Mitral Annulus Sizing","text":"<p>The mitral annulus is saddle-shaped and D-shaped \u2014 always measure in systole.</p> Measurement How Annular perimeter Trace in systole on sagittal + coronal planes Anteroposterior (AP) diameter Mid-point from AMVL to PMVL Mediolateral (ML) diameter Intercommissural distance Area Planimetry in reformatted plane perpendicular to annular ring Annular height SAo\u2013IVt commissural plane"},{"location":"valves/tavr_tmvr/#neo-lvot-assessment","title":"Neo-LVOT Assessment","text":"<p>Neo-LVOT Obstruction</p> <p>Critical pre-procedure measurement. Critical threshold: neo-LVOT area &lt;170\u2013190 mm\u00b2 is high risk for obstruction. Model by reformatting CT with virtual device in place; assess the triangle between device, AMVL, and IVS.</p>"},{"location":"valves/tavr_tmvr/#transseptal-planning","title":"Transseptal Planning","text":"Feature Measurement Fossa ovalis thickness Should be &lt;4 mm for puncture Height above annular plane Aim for 3.5\u20134.5 cm transseptal height Interatrial septum to annulus angle Determines trajectory"},{"location":"valves/tavr_tmvr/#ttvr-planning","title":"TTVR Planning","text":"<p>Tricuspid annulus is larger, more dynamic, and non-planar than mitral.</p> Measurement Notes Annular perimeter Key for sizing; measure in systole AP / ML diameters Large \u2014 often 40\u201355 mm Annular area RV dilation RVEDVi; affects device anchoring Coaptation gap Distance between TV leaflet free edges in systole IVC / SVC anatomy Relevant for certain devices"},{"location":"valves/tavr_tmvr/#laao-planning","title":"LAAO Planning","text":""},{"location":"valves/tavr_tmvr/#laa-anatomy","title":"LAA Anatomy","text":"<p>Morphologies (clinical relevance):</p> Morphology Description Notes Chicken wing Sharp bend in proximal LAA More protective against stroke? Cactus Multiple lobes off main trunk Complex \u2014 larger device may be needed Windsock Single dominant lobe Common Cauliflower No dominant lobe, irregular Highest stroke risk; most challenging"},{"location":"valves/tavr_tmvr/#key-measurements","title":"Key Measurements","text":"Measurement How Notes LAA ostium max D Widest diameter at ostium Device size = ostium D + 3\u20136 mm LAA ostium min D Narrowest diameter Elliptical \u2014 both dimensions needed LAA ostium area Planimetry Alternative to diameters Landing zone D 1\u20132 cm from ostium Where device sits LAA depth From ostium to tip (or first bend) Must be \u2265 device length LAA to LSPV Relationship \u2014 avoid impinging PV"},{"location":"valves/tavr_tmvr/#thrombus-protocol","title":"Thrombus Protocol","text":"<p>Delayed Phase (60 s)</p> <p>Residual enhancement on delayed phase effectively excludes thrombus. Absence of fill in on delayed = LAA thrombus \u2192 do NOT proceed to closure until resolved.</p>"},{"location":"valves/tavr_tmvr/#watchman-device-sizing","title":"Watchman Device Sizing","text":"Scenario Rule Max LAA ostium D \u226431.5 mm Standard Watchman FLX Max LAA ostium D &gt;31.5 mm Larger device or alternative Device size Max ostium D + 3\u20136 mm (8\u201320% compression target)"}]}